Keywords
Last Name
Institution

Stuart A. Aaronson

TitleFOUNDING CHAIR EMERITUS AND PROFESSOR
InstitutionMount Sinai
DepartmentOncological Sciences
Address
    Other Positions
    TitlePROFESSOR
    InstitutionMount Sinai
    DepartmentMedicine


     Bibliographic 
     selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Mungamuri SK, Murk W, Grumolato L, Bernstein E, Aaronson SA. Chromatin Modifications Sequentially Enhance ErbB2 Expression in ErbB2-Positive Breast Cancers. Cell Rep. 2013 Oct 31; 5(2):302-13.
      View in: PubMed
    2. Hamard PJ, Barthelery N, Hogstad B, Mungamuri SK, Tonnessen CA, Carvajal LA, Senturk E, Gillespie V, Aaronson SA, Merad M, Manfredi JJ. The C terminus of p53 regulates gene expression by multiple mechanisms in a target- and tissue-specific manner in vivo. Genes Dev. 2013 Sep 1; 27(17):1868-85.
      View in: PubMed
    3. Grumolato L, Liu G, Haremaki T, Mungamuri SK, Mong P, Akiri G, Lopez-Bergami P, Arita A, Anouar Y, Mlodzik M, Ronai ZA, Brody J, Weinstein DC, Aaronson SA. ß-Catenin-independent activation of TCF1/LEF1 in human hematopoietic tumor cells through interaction with ATF2 transcription factors. PLoS Genet. 2013; 9(8):e1003603.
      View in: PubMed
    4. Serysheva E, Berhane H, Grumolato L, Demir K, Balmer S, Bodak M, Boutros M, Aaronson S, Mlodzik M, Jenny A. Wnk kinases are positive regulators of canonical Wnt/ß-catenin signalling. EMBO Rep. 2013 Aug; 14(8):718-25.
      View in: PubMed
    5. Shapiro M, Akiri G, Chin C, Wisnivesky JP, Beasley MB, Weiser TS, Swanson SJ, Aaronson SA. Wnt pathway activation predicts increased risk of tumor recurrence in patients with stage I nonsmall cell lung cancer. Ann Surg. 2013 Mar; 257(3):548-54.
      View in: PubMed
    6. Kracikova M, Akiri G, George A, Sachidanandam R, Aaronson SA. A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis. Cell Death Differ. 2013 Apr; 20(4):576-88.
      View in: PubMed
    7. Brown-Endres L, Schoenfeld D, Tian F, Kim HG, Namba T, Muñoz-Fontela C, Mandinova A, Aaronson SA, Lee SW. Expression of the p53 target CDIP correlates with sensitivity to TNFa-induced apoptosis in cancer cells. Cancer Res. 2012 May 1; 72(9):2373-82.
      View in: PubMed
    8. Mungamuri SK, Benson EK, Wang S, Gu W, Lee SW, Aaronson SA. p53-mediated heterochromatin reorganization regulates its cell fate decisions. Nat Struct Mol Biol. 2012 May; 19(5):478-84, S1.
      View in: PubMed
    9. Muñoz-Fontela C, Pazos M, Delgado I, Murk W, Mungamuri SK, Lee SW, García-Sastre A, Moran TM, Aaronson SA. p53 serves as a host antiviral factor that enhances innate and adaptive immune responses to influenza A virus. J Immunol. 2011 Dec 15; 187(12):6428-36.
      View in: PubMed
    10. Dai C, Tang Y, Jung SY, Qin J, Aaronson SA, Gu W. Differential effects on p53-mediated cell cycle arrest vs. apoptosis by p90. Proc Natl Acad Sci U S A. 2011 Nov 22; 108(47):18937-42.
      View in: PubMed
    11. Muñoz-Fontela C, González D, Marcos-Villar L, Campagna M, Gallego P, González-Santamaría J, Herranz D, Gu W, Serrano M, Aaronson SA, Rivas C. Acetylation is indispensable for p53 antiviral activity. Cell Cycle. 2011 Nov 1; 10(21):3701-5.
      View in: PubMed
    12. Vijayakumar S, Liu G, Rus IA, Yao S, Chen Y, Akiri G, Grumolato L, Aaronson SA. High-frequency canonical Wnt activation in multiple sarcoma subtypes drives proliferation through a TCF/ß-catenin target gene, CDC25A. Cancer Cell. 2011 May 17; 19(5):601-12.
      View in: PubMed
    13. Kim HG, Hwang SY, Aaronson SA, Mandinova A, Lee SW. DDR1 receptor tyrosine kinase promotes prosurvival pathway through Notch1 activation. J Biol Chem. 2011 May 20; 286(20):17672-81.
      View in: PubMed
    14. Grumolato L, Liu G, Mong P, Mudbhary R, Biswas R, Arroyave R, Vijayakumar S, Economides AN, Aaronson SA. Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. Genes Dev. 2010 Nov 15; 24(22):2517-30.
      View in: PubMed
    15. Asciutti S, Akiri G, Grumolato L, Vijayakumar S, Aaronson SA. Diverse mechanisms of Wnt activation and effects of pathway inhibition on proliferation of human gastric carcinoma cells. Oncogene. 2011 Feb 24; 30(8):956-66.
      View in: PubMed
    16. Singh J, Yanfeng WA, Grumolato L, Aaronson SA, Mlodzik M. Abelson family kinases regulate Frizzled planar cell polarity signaling via Dsh phosphorylation. Genes Dev. 2010 Oct 1; 24(19):2157-68.
      View in: PubMed
    17. Benson EK, Lee SW, Aaronson SA. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence. J Cell Sci. 2010 Aug 1; 123(Pt 15):2605-12.
      View in: PubMed
    18. Singh J, Aaronson SA, Mlodzik M. Drosophila Abelson kinase mediates cell invasion and proliferation through two distinct MAPK pathways. Oncogene. 2010 Jul 15; 29(28):4033-45.
      View in: PubMed
    19. Ide T, Chu K, Aaronson SA, Lee SW. GAMT joins the p53 network: branching into metabolism. Cell Cycle. 2010 May; 9(9):1706-10.
      View in: PubMed
    20. Carrera S, de Verdier PJ, Khan Z, Zhao B, Mahale A, Bowman KJ, Zainol M, Jones GD, Lee SW, Aaronson SA, Macip S. Protection of cells in physiological oxygen tensions against DNA damage-induced apoptosis. J Biol Chem. 2010 Apr 30; 285(18):13658-65.
      View in: PubMed
    21. Rivas C, Aaronson SA, Munoz-Fontela C. Dual Role of p53 in Innate Antiviral Immunity. Viruses. 2010 Jan; 2(1):298-313.
      View in: PubMed
    22. Ide T, Brown-Endres L, Chu K, Ongusaha PP, Ohtsuka T, El-Deiry WS, Aaronson SA, Lee SW. GAMT, a p53-inducible modulator of apoptosis, is critical for the adaptive response to nutrient stress. Mol Cell. 2009 Nov 13; 36(3):379-92.
      View in: PubMed
    23. Lopez-Bergami P, Kim H, Dewing A, Goydos J, Aaronson S, Ronai Z. c-Jun regulates phosphoinositide-dependent kinase 1 transcription: implication for Akt and protein kinase C activities and melanoma tumorigenesis. J Biol Chem. 2010 Jan 8; 285(2):903-13.
      View in: PubMed
    24. Benson EK, Zhao B, Sassoon DA, Lee SW, Aaronson SA. Effects of p21 deletion in mouse models of premature aging. Cell Cycle. 2009 Jul 1; 8(13):2002-4.
      View in: PubMed
    25. Akiri G, Cherian MM, Vijayakumar S, Liu G, Bafico A, Aaronson SA. Wnt pathway aberrations including autocrine Wnt activation occur at high frequency in human non-small-cell lung carcinoma. Oncogene. 2009 May 28; 28(21):2163-72.
      View in: PubMed
    26. Galluzzi L, Aaronson SA, Abrams J, Alnemri ES, Andrews DW, Baehrecke EH, Bazan NG, Blagosklonny MV, Blomgren K, Borner C, Bredesen DE, Brenner C, Castedo M, Cidlowski JA, Ciechanover A, Cohen GM, De Laurenzi V, De Maria R, Deshmukh M, Dynlacht BD, El-Deiry WS, Flavell RA, Fulda S, Garrido C, Golstein P, Gougeon ML, Green DR, Gronemeyer H, Hajnóczky G, Hardwick JM, Hengartner MO, Ichijo H, Jäättelä M, Kepp O, Kimchi A, Klionsky DJ, Knight RA, Kornbluth S, Kumar S, Levine B, Lipton SA, Lugli E, Madeo F, Malomi W, Marine JC, Martin SJ, Medema JP, Mehlen P, Melino G, Moll UM, Morselli E, Nagata S, Nicholson DW, Nicotera P, Nuñez G, Oren M, Penninger J, Pervaiz S, Peter ME, Piacentini M, Prehn JH, Puthalakath H, Rabinovich GA, Rizzuto R, Rodrigues CM, Rubinsztein DC, Rudel T, Scorrano L, Simon HU, Steller H, Tschopp J, Tsujimoto Y, Vandenabeele P, Vitale I, Vousden KH, Youle RJ, Yuan J, Zhivotovsky B, Kroemer G. Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes. Cell Death Differ. 2009 Aug; 16(8):1093-107.
      View in: PubMed
    27. Liu G, Vijayakumar S, Grumolato L, Arroyave R, Qiao H, Akiri G, Aaronson SA. Canonical Wnts function as potent regulators of osteogenesis by human mesenchymal stem cells. J Cell Biol. 2009 Apr 6; 185(1):67-75.
      View in: PubMed
    28. Zhao B, Benson EK, Qiao R, Wang X, Kim S, Manfredi JJ, Lee SW, Aaronson SA. Cellular senescence and organismal ageing in the absence of p21(CIP1/WAF1) in ku80(-/-) mice. EMBO Rep. 2009 Jan; 10(1):71-8.
      View in: PubMed
    29. Ongusaha PP, Qi HH, Raj L, Kim YB, Aaronson SA, Davis RJ, Shi Y, Liao JK, Lee SW. Identification of ROCK1 as an upstream activator of the JIP-3 to JNK signaling axis in response to UVB damage. Sci Signal. 2008; 1(47):ra14.
      View in: PubMed
    30. Muñoz-Fontela C, Macip S, Martínez-Sobrido L, Brown L, Ashour J, García-Sastre A, Lee SW, Aaronson SA. Transcriptional role of p53 in interferon-mediated antiviral immunity. J Exp Med. 2008 Aug 4; 205(8):1929-38.
      View in: PubMed
    31. Mahale AM, Khan ZA, Igarashi M, Nanjangud GJ, Qiao RF, Yao S, Lee SW, Aaronson SA. Clonal selection in malignant transformation of human fibroblasts transduced with defined cellular oncogenes. Cancer Res. 2008 Mar 1; 68(5):1417-26.
      View in: PubMed
    32. Das S, Boswell SA, Aaronson SA, Lee SW. P53 promoter selection: choosing between life and death. Cell Cycle. 2008 Jan 15; 7(2):154-7.
      View in: PubMed
    33. Das S, Raj L, Zhao B, Kimura Y, Bernstein A, Aaronson SA, Lee SW. Hzf Determines cell survival upon genotoxic stress by modulating p53 transactivation. Cell. 2007 Aug 24; 130(4):624-37.
      View in: PubMed
    34. Brown L, Ongusaha PP, Kim HG, Nuti S, Mandinova A, Lee JW, Khosravi-Far R, Aaronson SA, Lee SW. CDIP, a novel pro-apoptotic gene, regulates TNFalpha-mediated apoptosis in a p53-dependent manner. EMBO J. 2007 Jul 25; 26(14):3410-22.
      View in: PubMed
    35. Liu XH, Kirschenbaum A, Yao S, Liu G, Aaronson SA, Levine AC. Androgen-induced Wnt signaling in preosteoblasts promotes the growth of MDA-PCa-2b human prostate cancer cells. Cancer Res. 2007 Jun 15; 67(12):5747-53.
      View in: PubMed
    36. Lopez-Bergami P, Huang C, Goydos JS, Yip D, Bar-Eli M, Herlyn M, Smalley KS, Mahale A, Eroshkin A, Aaronson S, Ronai Z. Rewired ERK-JNK signaling pathways in melanoma. Cancer Cell. 2007 May; 11(5):447-60.
      View in: PubMed
    37. Ongusaha PP, Kim HG, Boswell SA, Ridley AJ, Der CJ, Dotto GP, Kim YB, Aaronson SA, Lee SW. RhoE is a pro-survival p53 target gene that inhibits ROCK I-mediated apoptosis in response to genotoxic stress. Curr Biol. 2006 Dec 19; 16(24):2466-72.
      View in: PubMed
    38. Das S, Ongusaha PP, Yang YS, Park JM, Aaronson SA, Lee SW. Discoidin domain receptor 1 receptor tyrosine kinase induces cyclooxygenase-2 and promotes chemoresistance through nuclear factor-kappaB pathway activation. Cancer Res. 2006 Aug 15; 66(16):8123-30.
      View in: PubMed
    39. Macip S, Kosoy A, Lee SW, O'Connell MJ, Aaronson SA. Oxidative stress induces a prolonged but reversible arrest in p53-null cancer cells, involving a Chk1-dependent G2 checkpoint. Oncogene. 2006 Oct 5; 25(45):6037-47.
      View in: PubMed
    40. Bernstein JL, Godbold JH, Raptis G, Watson MA, Levinson B, Aaronson SA, Fleming TP. Identification of mammaglobin as a novel serum marker for breast cancer. Clin Cancer Res. 2005 Sep 15; 11(18):6528-35.
      View in: PubMed
    41. Hall CL, Bafico A, Dai J, Aaronson SA, Keller ET. Prostate cancer cells promote osteoblastic bone metastases through Wnts. Cancer Res. 2005 Sep 1; 65(17):7554-60.
      View in: PubMed
    42. Liu G, Bafico A, Aaronson SA. The mechanism of endogenous receptor activation functionally distinguishes prototype canonical and noncanonical Wnts. Mol Cell Biol. 2005 May; 25(9):3475-82.
      View in: PubMed
    43. Manfredi JJ, Dong J, Liu WJ, Resnick-Silverman L, Qiao R, Chahinian P, Saric M, Gibbs AR, Phillips JI, Murray J, Axten CW, Nolan RP, Aaronson SA. Evidence against a role for SV40 in human mesothelioma. Cancer Res. 2005 Apr 1; 65(7):2602-9.
      View in: PubMed
    44. Aaronson S. Teaching resources. Growth factor and receptor tyrosine kinases. Sci STKE. 2005 Feb 22; 2005(272):tr6.
      View in: PubMed
    45. Ibrahimi OA, Yeh BK, Eliseenkova AV, Zhang F, Olsen SK, Igarashi M, Aaronson SA, Linhardt RJ, Mohammadi M. Analysis of mutations in fibroblast growth factor (FGF) and a pathogenic mutation in FGF receptor (FGFR) provides direct evidence for the symmetric two-end model for FGFR dimerization. Mol Cell Biol. 2005 Jan; 25(2):671-84.
      View in: PubMed
    46. Bafico A, Liu G, Goldin L, Harris V, Aaronson SA. An autocrine mechanism for constitutive Wnt pathway activation in human cancer cells. Cancer Cell. 2004 Nov; 6(5):497-506.
      View in: PubMed
    47. Schoenfeld AR, Apgar S, Dolios G, Wang R, Aaronson SA. BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol Cell Biol. 2004 Sep; 24(17):7444-55.
      View in: PubMed
    48. Ohtsuka T, Ryu H, Minamishima YA, Macip S, Sagara J, Nakayama KI, Aaronson SA, Lee SW. ASC is a Bax adaptor and regulates the p53-Bax mitochondrial apoptosis pathway. Nat Cell Biol. 2004 Feb; 6(2):121-8.
      View in: PubMed
    49. Macip S, Igarashi M, Berggren P, Yu J, Lee SW, Aaronson SA. Influence of induced reactive oxygen species in p53-mediated cell fate decisions. Mol Cell Biol. 2003 Dec; 23(23):8576-85.
      View in: PubMed
    50. Liu G, Bafico A, Harris VK, Aaronson SA. A novel mechanism for Wnt activation of canonical signaling through the LRP6 receptor. Mol Cell Biol. 2003 Aug; 23(16):5825-35.
      View in: PubMed
    51. Dong J, Phelps RG, Qiao R, Yao S, Benard O, Ronai Z, Aaronson SA. BRAF oncogenic mutations correlate with progression rather than initiation of human melanoma. Cancer Res. 2003 Jul 15; 63(14):3883-5.
      View in: PubMed
    52. Ongusaha PP, Kim JI, Fang L, Wong TW, Yancopoulos GD, Aaronson SA, Lee SW. p53 induction and activation of DDR1 kinase counteract p53-mediated apoptosis and influence p53 regulation through a positive feedback loop. EMBO J. 2003 Mar 17; 22(6):1289-301.
      View in: PubMed
    53. Yeh BK, Igarashi M, Eliseenkova AV, Plotnikov AN, Sher I, Ron D, Aaronson SA, Mohammadi M. Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors. Proc Natl Acad Sci U S A. 2003 Mar 4; 100(5):2266-71.
      View in: PubMed
    54. Han JA, Kim JI, Ongusaha PP, Hwang DH, Ballou LR, Mahale A, Aaronson SA, Lee SW. P53-mediated induction of Cox-2 counteracts p53- or genotoxic stress-induced apoptosis. EMBO J. 2002 Nov 1; 21(21):5635-44.
      View in: PubMed
    55. Ramanathan Y, Zhang H, Aris V, Soteropoulos P, Aaronson SA, Tolias PP. Functional cloning, sorting, and expression profiling of nucleic acid-binding proteins. Genome Res. 2002 Aug; 12(8):1175-84.
      View in: PubMed
    56. Spiegelman VS, Tang W, Chan AM, Igarashi M, Aaronson SA, Sassoon DA, Katoh M, Slaga TJ, Fuchs SY. Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling. J Biol Chem. 2002 Sep 27; 277(39):36624-30.
      View in: PubMed
    57. Macip S, Igarashi M, Fang L, Chen A, Pan ZQ, Lee SW, Aaronson SA. Inhibition of p21-mediated ROS accumulation can rescue p21-induced senescence. EMBO J. 2002 May 1; 21(9):2180-8.
      View in: PubMed
    58. Bafico A, Liu G, Yaniv A, Gazit A, Aaronson SA. Novel mechanism of Wnt signalling inhibition mediated by Dickkopf-1 interaction with LRP6/Arrow. Nat Cell Biol. 2001 Jul; 3(7):683-6.
      View in: PubMed
    59. Fang L, Li G, Liu G, Lee SW, Aaronson SA. p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades. EMBO J. 2001 Apr 17; 20(8):1931-9.
      View in: PubMed
    60. Arizti P, Fang L, Park I, Yin Y, Solomon E, Ouchi T, Aaronson SA, Lee SW. Tumor suppressor p53 is required to modulate BRCA1 expression. Mol Cell Biol. 2000 Oct; 20(20):7450-9.
      View in: PubMed
    61. Lee SW, Fang L, Igarashi M, Ouchi T, Lu KP, Aaronson SA. Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc Natl Acad Sci U S A. 2000 Jul 18; 97(15):8302-5.
      View in: PubMed
    62. Ouchi T, Lee SW, Ouchi M, Aaronson SA, Horvath CM. Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes. Proc Natl Acad Sci U S A. 2000 May 9; 97(10):5208-13.
      View in: PubMed
    63. Lee SW, Reimer CL, Fang L, Iruela-Arispe ML, Aaronson SA. Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol. 2000 Mar; 20(5):1723-32.
      View in: PubMed
    64. Hazan RB, Phillips GR, Qiao RF, Norton L, Aaronson SA. Exogenous expression of N-cadherin in breast cancer cells induces cell migration, invasion, and metastasis. J Cell Biol. 2000 Feb 21; 148(4):779-90.
      View in: PubMed
    65. Fang L, Lee SW, Aaronson SA. Comparative analysis of p73 and p53 regulation and effector functions. J Cell Biol. 1999 Nov 15; 147(4):823-30.
      View in: PubMed
    66. Gazit A, Yaniv A, Bafico A, Pramila T, Igarashi M, Kitajewski J, Aaronson SA. Human frizzled 1 interacts with transforming Wnts to transduce a TCF dependent transcriptional response. Oncogene. 1999 Oct 28; 18(44):5959-66.
      View in: PubMed
    67. Blaho JA, Aaronson SA. Convicting a human tumor virus: guilt by association? Proc Natl Acad Sci U S A. 1999 Jul 6; 96(14):7619-21.
      View in: PubMed
    68. Fedi P, Bafico A, Nieto Soria A, Burgess WH, Miki T, Bottaro DP, Kraus MH, Aaronson SA. Isolation and biochemical characterization of the human Dkk-1 homologue, a novel inhibitor of mammalian Wnt signaling. J Biol Chem. 1999 Jul 2; 274(27):19465-72.
      View in: PubMed
    69. Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA. Interaction of frizzled related protein (FRP) with Wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of Wnt signaling. J Biol Chem. 1999 Jun 4; 274(23):16180-7.
      View in: PubMed
    70. Fang L, Igarashi M, Leung J, Sugrue MM, Lee SW, Aaronson SA. p21Waf1/Cip1/Sdi1 induces permanent growth arrest with markers of replicative senescence in human tumor cells lacking functional p53. Oncogene. 1999 May 6; 18(18):2789-97.
      View in: PubMed
    71. Reimer CL, Borras AM, Kurdistani SK, Garreau JR, Chung M, Aaronson SA, Lee SW. Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells. J Biol Chem. 1999 Apr 16; 274(16):11022-9.
      View in: PubMed
    72. Marmorstein LY, Ouchi T, Aaronson SA. The BRCA2 gene product functionally interacts with p53 and RAD51. Proc Natl Acad Sci U S A. 1998 Nov 10; 95(23):13869-74.
      View in: PubMed
    73. Levine AC, Liu XH, Greenberg PD, Eliashvili M, Schiff JD, Aaronson SA, Holland JF, Kirschenbaum A. Androgens induce the expression of vascular endothelial growth factor in human fetal prostatic fibroblasts. Endocrinology. 1998 Nov; 139(11):4672-8.
      View in: PubMed
    74. Kurdistani SK, Arizti P, Reimer CL, Sugrue MM, Aaronson SA, Lee SW. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer Res. 1998 Oct 1; 58(19):4439-44.
      View in: PubMed
    75. Bafico A, Gazit A, Wu-Morgan SS, Yaniv A, Aaronson SA. Characterization of Wnt-1 and Wnt-2 induced growth alterations and signaling pathways in NIH3T3 fibroblasts. Oncogene. 1998 May 28; 16(21):2819-25.
      View in: PubMed
    76. Igarashi M, Finch PW, Aaronson SA. Characterization of recombinant human fibroblast growth factor (FGF)-10 reveals functional similarities with keratinocyte growth factor (FGF-7). J Biol Chem. 1998 May 22; 273(21):13230-5.
      View in: PubMed
    77. Montesano R, Soriano JV, Malinda KM, Ponce ML, Bafico A, Kleinman HK, Bottaro DP, Aaronson SA. Differential effects of hepatocyte growth factor isoforms on epithelial and endothelial tubulogenesis. Cell Growth Differ. 1998 May; 9(5):355-65.
      View in: PubMed
    78. Ouchi T, Monteiro AN, August A, Aaronson SA, Hanafusa H. BRCA1 regulates p53-dependent gene expression. Proc Natl Acad Sci U S A. 1998 Mar 3; 95(5):2302-6.
      View in: PubMed
    79. Zimonjic DB, Kelley MJ, Rubin JS, Aaronson SA, Popescu NC. Fluorescence in situ hybridization analysis of keratinocyte growth factor gene amplification and dispersion in evolution of great apes and humans. Proc Natl Acad Sci U S A. 1997 Oct 14; 94(21):11461-5.
      View in: PubMed
    80. Sugrue MM, Shin DY, Lee SW, Aaronson SA. Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53. Proc Natl Acad Sci U S A. 1997 Sep 2; 94(18):9648-53.
      View in: PubMed
    81. Finch PW, He X, Kelley MJ, Uren A, Schaudies RP, Popescu NC, Rudikoff S, Aaronson SA, Varmus HE, Rubin JS. Purification and molecular cloning of a secreted, Frizzled-related antagonist of Wnt action. Proc Natl Acad Sci U S A. 1997 Jun 24; 94(13):6770-5.
      View in: PubMed
    82. Shin DY, Ishibashi T, Choi TS, Chung E, Chung IY, Aaronson SA, Bottaro DP. A novel human ERK phosphatase regulates H-ras and v-raf signal transduction. Oncogene. 1997 Jun 5; 14(22):2633-9.
      View in: PubMed
    83. Bear D, Jacobson G, Aaronson S, Hanson A. Telemedicine in Psychiatry: making the dream reality. Am J Psychiatry. 1997 Jun; 154(6):884-5.
      View in: PubMed
    84. Diez de Medina SG, Chopin D, El Marjou A, Delouvée A, LaRochelle WJ, Hoznek A, Abbou C, Aaronson SA, Thiery JP, Radvanyi F. Decreased expression of keratinocyte growth factor receptor in a subset of human transitional cell bladder carcinomas. Oncogene. 1997 Jan 23; 14(3):323-30.
      View in: PubMed
    85. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A. 1997 Jan 21; 94(2):701-6.
      View in: PubMed
    86. Kirschenbaum A, Wang JP, Ren M, Schiff JD, Aaronson SA, Droller MJ, Ferrara N, Holland JF, Levine AC. Inhibition of vascular endothelial cell growth factor suppresses the in vivo growth of human prostate tumors. Urol Oncol. 1997 Jan-Feb; 3(1):3-10.
      View in: PubMed
    87. Sugimura Y, Foster BA, Hom YK, Lipschutz JH, Rubin JS, Finch PW, Aaronson SA, Hayashi N, Kawamura J, Cunha GR. Keratinocyte growth factor (KGF) can replace testosterone in the ductal branching morphogenesis of the rat ventral prostate. Int J Dev Biol. 1996 Oct; 40(5):941-51.
      View in: PubMed
    88. Aaronson S, Hartmann H. Reform, not rhetoric: a critique of welfare policy and charting of new directions. Am J Orthopsychiatry. 1996 Oct; 66(4):583-98.
      View in: PubMed
    89. Tachibana M, Takeda K, Nobukuni Y, Urabe K, Long JE, Meyers KA, Aaronson SA, Miki T. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat Genet. 1996 Sep; 14(1):50-4.
      View in: PubMed
    90. Cioce V, Csaky KG, Chan AM, Bottaro DP, Taylor WG, Jensen R, Aaronson SA, Rubin JS. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J Biol Chem. 1996 May 31; 271(22):13110-5.
      View in: PubMed
    91. Breuninger LM, Paul S, Gaughan K, Miki T, Chan A, Aaronson SA, Kruh GD. Expression of multidrug resistance-associated protein in NIH/3T3 cells confers multidrug resistance associated with increased drug efflux and altered intracellular drug distribution. Cancer Res. 1995 Nov 15; 55(22):5342-7.
      View in: PubMed
    92. Marchese C, Chedid M, Dirsch OR, Csaky KG, Santanelli F, Latini C, LaRochelle WJ, Torrisi MR, Aaronson SA. Modulation of keratinocyte growth factor and its receptor in reepithelializing human skin. J Exp Med. 1995 Nov 1; 182(5):1369-76.
      View in: PubMed
    93. Huang Y, Saez R, Chao L, Santos E, Aaronson SA, Chan AM. A novel insertional mutation in the TC21 gene activates its transforming activity in a human leiomyosarcoma cell line. Oncogene. 1995 Oct 5; 11(7):1255-60.
      View in: PubMed
    94. Aroca P, Bottaro DP, Ishibashi T, Aaronson SA, Santos E. Human dual specificity phosphatase VHR activates maturation promotion factor and triggers meiotic maturation in Xenopus oocytes. J Biol Chem. 1995 Jun 9; 270(23):14229-34.
      View in: PubMed
    95. Lorenzi MV, Long JE, Miki T, Aaronson SA. Expression cloning, developmental expression and chromosomal localization of fibroblast growth factor-8. Oncogene. 1995 May 18; 10(10):2051-5.
      View in: PubMed
    96. Alimandi M, Romano A, Curia MC, Muraro R, Fedi P, Aaronson SA, Di Fiore PP, Kraus MH. Cooperative signaling of ErbB3 and ErbB2 in neoplastic transformation and human mammary carcinomas. Oncogene. 1995 May 4; 10(9):1813-21.
      View in: PubMed
    97. Aaronson S. Lung cancer: emerging therapeutic approaches based on molecular genetics. Mt Sinai J Med. 1995 May; 62(3):204-5.
      View in: PubMed
    98. LaRochelle WJ, Dirsch OR, Finch PW, Cheon HG, May M, Marchese C, Pierce JH, Aaronson SA. Specific receptor detection by a functional keratinocyte growth factor-immunoglobulin chimera. J Cell Biol. 1995 Apr; 129(2):357-66.
      View in: PubMed
    99. Miki T, Aaronson SA. Isolation of oncogenes by expression cDNA cloning. Methods Enzymol. 1995; 254:196-206.
      View in: PubMed
    100. Ishibashi T, Bottaro DP, Michieli P, Kelley CA, Aaronson SA. A novel dual specificity phosphatase induced by serum stimulation and heat shock. J Biol Chem. 1994 Nov 25; 269(47):29897-902.
      View in: PubMed
    101. Saez R, Chan AM, Miki T, Aaronson SA. Oncogenic activation of human R-ras by point mutations analogous to those of prototype H-ras oncogenes. Oncogene. 1994 Oct; 9(10):2977-82.
      View in: PubMed
    102. Chan AM, Miki T, Meyers KA, Aaronson SA. A human oncogene of the RAS superfamily unmasked by expression cDNA cloning. Proc Natl Acad Sci U S A. 1994 Aug 2; 91(16):7558-62.
      View in: PubMed
    103. Goldstein DJ, Li W, Wang LM, Heidaran MA, Aaronson S, Shinn R, Schlegel R, Pierce JH. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation. J Virol. 1994 Jul; 68(7):4432-41.
      View in: PubMed
    104. Chedid M, Rubin JS, Csaky KG, Aaronson SA. Regulation of keratinocyte growth factor gene expression by interleukin 1. J Biol Chem. 1994 Apr 8; 269(14):10753-7.
      View in: PubMed
    105. Koji T, Chedid M, Rubin JS, Slayden OD, Csaky KG, Aaronson SA, Brenner RM. Progesterone-dependent expression of keratinocyte growth factor mRNA in stromal cells of the primate endometrium: keratinocyte growth factor as a progestomedin. J Cell Biol. 1994 Apr; 125(2):393-401.
      View in: PubMed
    106. Kruh GD, Chan A, Myers K, Gaughan K, Miki T, Aaronson SA. Expression complementary DNA library transfer establishes mrp as a multidrug resistance gene. Cancer Res. 1994 Apr 1; 54(7):1649-52.
      View in: PubMed
    107. Cheon HG, LaRochelle WJ, Bottaro DP, Burgess WH, Aaronson SA. High-affinity binding sites for related fibroblast growth factor ligands reside within different receptor immunoglobulin-like domains. Proc Natl Acad Sci U S A. 1994 Feb 1; 91(3):989-93.
      View in: PubMed
    108. Alarid ET, Rubin JS, Young P, Chedid M, Ron D, Aaronson SA, Cunha GR. Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci U S A. 1994 Feb 1; 91(3):1074-8.
      View in: PubMed
    109. Strain AJ, McGuinness G, Rubin JS, Aaronson SA. Keratinocyte growth factor and fibroblast growth factor action on DNA synthesis in rat and human hepatocytes: modulation by heparin. Exp Cell Res. 1994 Feb; 210(2):253-9.
      View in: PubMed
    110. Beeler JF, LaRochelle WJ, Chedid M, Tronick SR, Aaronson SA. Prokaryotic expression cloning of a novel human tyrosine kinase. Mol Cell Biol. 1994 Feb; 14(2):982-8.
      View in: PubMed
    111. Hart MJ, Eva A, Zangrilli D, Aaronson SA, Evans T, Cerione RA, Zheng Y. Cellular transformation and guanine nucleotide exchange activity are catalyzed by a common domain on the dbl oncogene product. J Biol Chem. 1994 Jan 7; 269(1):62-5.
      View in: PubMed
    112. Rubin JS, Bottaro DP, Aaronson SA. Hepatocyte growth factor/scatter factor and its receptor, the c-met proto-oncogene product. Biochim Biophys Acta. 1993 Dec 23; 1155(3):357-71.
      View in: PubMed
    113. May M, Aaronson SA, LaRochelle WJ. Platelet-derived growth factor AB heterodimer interchain interactions influence secretion as well as receptor binding and activation. Biochemistry. 1993 Nov 2; 32(43):11734-40.
      View in: PubMed
    114. Wang LM, Myers MG, Sun XJ, Aaronson SA, White M, Pierce JH. IRS-1: essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science. 1993 Sep 17; 261(5128):1591-4.
      View in: PubMed
    115. Cuadrado A, Bruder JT, Heidaran MA, App H, Rapp UR, Aaronson SA. H-ras and raf-1 cooperate in transformation of NIH3T3 fibroblasts. Oncogene. 1993 Sep; 8(9):2443-8.
      View in: PubMed
    116. Suzuki M, Itoh T, Osada H, Rubin JS, Aaronson SA, Suzuki T, Koga N, Saito T, Mitsui Y. Spleen-derived growth factor, SDGF-3, is identified as keratinocyte growth factor (KGF). FEBS Lett. 1993 Aug 9; 328(1-2):17-20.
      View in: PubMed
    117. Panos RJ, Rubin JS, Csaky KG, Aaronson SA, Mason RJ. Keratinocyte growth factor and hepatocyte growth factor/scatter factor are heparin-binding growth factors for alveolar type II cells in fibroblast-conditioned medium. J Clin Invest. 1993 Aug; 92(2):969-77.
      View in: PubMed
    118. LaRochelle WJ, Jensen RA, Heidaran MA, May-Siroff M, Wang LM, Aaronson SA, Pierce JH. Inhibition of platelet-derived growth factor autocrine growth stimulation by a monoclonal antibody to the human alpha platelet-derived growth factor receptor. Cell Growth Differ. 1993 Jul; 4(7):547-53.
      View in: PubMed
    119. Bottaro DP, Fortney E, Rubin JS, Aaronson SA. A keratinocyte growth factor receptor-derived peptide antagonist identifies part of the ligand binding site. J Biol Chem. 1993 May 5; 268(13):9180-3.
      View in: PubMed
    120. Heidaran MA, Beeler JF, Yu JC, Ishibashi T, LaRochelle WJ, Pierce JH, Aaronson SA. Differences in substrate specificities of alpha and beta platelet-derived growth factor (PDGF) receptors. Correlation with their ability to mediate PDGF transforming functions. J Biol Chem. 1993 May 5; 268(13):9287-95.
      View in: PubMed
    121. Chan AM, Chedid M, McGovern ES, Popescu NC, Miki T, Aaronson SA. Expression cDNA cloning of a serine kinase transforming gene. Oncogene. 1993 May; 8(5):1329-33.
      View in: PubMed
    122. Aaronson SA. Growing families of fibroblast growth factors and receptors. Jpn J Cancer Res. 1993 May; 84(5):inside front cover.
      View in: PubMed
    123. Wang LM, Keegan AD, Li W, Lienhard GE, Pacini S, Gutkind JS, Myers MG, Sun XJ, White MF, Aaronson SA, et al. Common elements in interleukin 4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc Natl Acad Sci U S A. 1993 May 1; 90(9):4032-6.
      View in: PubMed
    124. Kraus MH, Fedi P, Starks V, Muraro R, Aaronson SA. Demonstration of ligand-dependent signaling by the erbB-3 tyrosine kinase and its constitutive activation in human breast tumor cells. Proc Natl Acad Sci U S A. 1993 Apr 1; 90(7):2900-4.
      View in: PubMed
    125. Ron D, Bottaro DP, Finch PW, Morris D, Rubin JS, Aaronson SA. Expression of biologically active recombinant keratinocyte growth factor. Structure/function analysis of amino-terminal truncation mutants. J Biol Chem. 1993 Feb 5; 268(4):2984-8.
      View in: PubMed
    126. Chan AM, Fleming TP, McGovern ES, Chedid M, Miki T, Aaronson SA. Expression cDNA cloning of a transforming gene encoding the wild-type G alpha 12 gene product. Mol Cell Biol. 1993 Feb; 13(2):762-8.
      View in: PubMed
    127. Aaronson SA, Miki T, Meyers K, Chan A. Growth factors and malignant transformation. Adv Exp Med Biol. 1993; 348:7-22.
      View in: PubMed
    128. Chan A, Rubin J, Bottaro D, Hirschfield D, Chedid M, Aaronson SA. Isoforms of human HGF and their biological activities. EXS. 1993; 65:67-79.
      View in: PubMed
    129. Ishibashi T, Bottaro DP, Chan A, Miki T, Aaronson SA. Expression cloning of a human dual-specificity phosphatase. Proc Natl Acad Sci U S A. 1992 Dec 15; 89(24):12170-4.
      View in: PubMed
    130. Rong S, Bodescot M, Blair D, Dunn J, Nakamura T, Mizuno K, Park M, Chan A, Aaronson S, Vande Woude GF. Tumorigenicity of the met proto-oncogene and the gene for hepatocyte growth factor. Mol Cell Biol. 1992 Nov; 12(11):5152-8.
      View in: PubMed
    131. Kelley MJ, Pech M, Seuanez HN, Rubin JS, O'Brien SJ, Aaronson SA. Emergence of the keratinocyte growth factor multigene family during the great ape radiation. Proc Natl Acad Sci U S A. 1992 Oct 1; 89(19):9287-91.
      View in: PubMed
    132. Fleming TP, Matsui T, Aaronson SA. Platelet-derived growth factor (PDGF) receptor activation in cell transformation and human malignancy. Exp Gerontol. 1992 Sep-Dec; 27(5-6):523-32.
      View in: PubMed
    133. Molloy CJ, Fleming TP, Bottaro DP, Cuadrado A, Aaronson SA. Platelet-derived growth factor stimulation of GTPase-activating protein tyrosine phosphorylation in control and c-H-ras-expressing NIH 3T3 cells correlates with p21ras activation. Mol Cell Biol. 1992 Sep; 12(9):3903-9.
      View in: PubMed
    134. LaRochelle WJ, Pierce JH, May-Siroff M, Giese N, Aaronson SA. Five PDGF B amino acid substitutions convert PDGF A to a PDGF B-like transforming molecule. J Biol Chem. 1992 Aug 25; 267(24):17074-7.
      View in: PubMed
    135. Fleming TP, Saxena A, Clark WC, Robertson JT, Oldfield EH, Aaronson SA, Ali IU. Amplification and/or overexpression of platelet-derived growth factor receptors and epidermal growth factor receptor in human glial tumors. Cancer Res. 1992 Aug 15; 52(16):4550-3.
      View in: PubMed
    136. Fleming TP, Matsui T, Heidaran MA, Molloy CJ, Artrip J, Aaronson SA. Demonstration of an activated platelet-derived growth factor autocrine pathway and its role in human tumor cell proliferation in vitro. Oncogene. 1992 Jul; 7(7):1355-9.
      View in: PubMed
    137. Heidaran MA, Yu JC, Jensen RA, Pierce JH, Aaronson SA. A deletion in the extracellular domain of the alpha platelet-derived growth factor (PDGF) receptor differentially impairs PDGF-AA and PDGF-BB binding affinities. J Biol Chem. 1992 Feb 15; 267(5):2884-7.
      View in: PubMed
    138. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM, Aaronson SA. Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci U S A. 1992 Jan 1; 89(1):246-50.
      View in: PubMed
    139. Chan AM, Rubin JS, Bottaro DP, Hirschfield DW, Chedid M, Aaronson SA. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science. 1991 Nov 29; 254(5036):1382-5.
      View in: PubMed
    140. Hart MJ, Eva A, Evans T, Aaronson SA, Cerione RA. Catalysis of guanine nucleotide exchange on the CDC42Hs protein by the dbl oncogene product. Nature. 1991 Nov 28; 354(6351):311-4.
      View in: PubMed
    141. Aaronson SA. Growth factors and cancer. Science. 1991 Nov 22; 254(5035):1146-53.
      View in: PubMed
    142. Heidaran MA, Pierce JH, Yu JC, Lombardi D, Artrip JE, Fleming TP, Thomason A, Aaronson SA. Role of alpha beta receptor heterodimer formation in beta platelet-derived growth factor (PDGF) receptor activation by PDGF-AB. J Biol Chem. 1991 Oct 25; 266(30):20232-7.
      View in: PubMed
    143. LaRochelle WJ, May-Siroff M, Robbins KC, Aaronson SA. A novel mechanism regulating growth factor association with the cell surface: identification of a PDGF retention domain. Genes Dev. 1991 Jul; 5(7):1191-9.
      View in: PubMed
    144. Pierce JH, Arnstein P, DiMarco E, Artrip J, Kraus MH, Lonardo F, Di Fiore PP, Aaronson SA. Oncogenic potential of erbB-2 in human mammary epithelial cells. Oncogene. 1991 Jul; 6(7):1189-94.
      View in: PubMed
    145. Yu JC, Heidaran MA, Pierce JH, Gutkind JS, Lombardi D, Ruggiero M, Aaronson SA. Tyrosine mutations within the alpha platelet-derived growth factor receptor kinase insert domain abrogate receptor-associated phosphatidylinositol-3 kinase activity without affecting mitogenic or chemotactic signal transduction. Mol Cell Biol. 1991 Jul; 11(7):3780-5.
      View in: PubMed
    146. Miki T, Fleming TP, Crescenzi M, Molloy CJ, Blam SB, Reynolds SH, Aaronson SA. Development of a highly efficient expression cDNA cloning system: application to oncogene isolation. Proc Natl Acad Sci U S A. 1991 Jun 15; 88(12):5167-71.
      View in: PubMed
    147. Takahashi R, Hashimoto T, Xu HJ, Hu SX, Matsui T, Miki T, Bigo-Marshall H, Aaronson SA, Benedict WF. The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells. Proc Natl Acad Sci U S A. 1991 Jun 15; 88(12):5257-61.
      View in: PubMed
    148. Smith EA, Seldin MF, Martinez L, Watson ML, Choudhury GG, Lalley PA, Pierce J, Aaronson S, Barker J, Naylor SL, et al. Mouse platelet-derived growth factor receptor alpha gene is deleted in W19H and patch mutations on chromosome 5. Proc Natl Acad Sci U S A. 1991 Jun 1; 88(11):4811-5.
      View in: PubMed
    149. Ron D, Zannini M, Lewis M, Wickner RB, Hunt LT, Graziani G, Tronick SR, Aaronson SA, Eva A. A region of proto-dbl essential for its transforming activity shows sequence similarity to a yeast cell cycle gene, CDC24, and the human breakpoint cluster gene, bcr. New Biol. 1991 Apr; 3(4):372-9.
      View in: PubMed
    150. Bottaro DP, Rubin JS, Faletto DL, Chan AM, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science. 1991 Feb 15; 251(4995):802-4.
      View in: PubMed
    151. Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D, Aaronson SA. Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science. 1991 Jan 4; 251(4989):72-5.
      View in: PubMed
    152. Kraus MH, Aaronson SA. Detection and isolation of novel protein-tyrosine kinase genes employing reduced stringency hybridization. Methods Enzymol. 1991; 200:546-56.
      View in: PubMed
    153. Aaronson SA. Influences of growth factors and their signaling pathways in malignancy. Harvey Lect. 1991-1992; 87:17-34.
      View in: PubMed
    154. Di Fiore PP, Segatto O, Aaronson SA. Cloning, expression, and biological effects of erbB-2/neu gene in mammalian cells. Methods Enzymol. 1991; 198:272-7.
      View in: PubMed
    155. Aaronson SA, Bottaro DP, Miki T, Ron D, Finch PW, Fleming TP, Ahn J, Taylor WG, Rubin JS. Keratinocyte growth factor. A fibroblast growth factor family member with unusual target cell specificity. Ann N Y Acad Sci. 1991; 638:62-77.
      View in: PubMed
    156. Heidaran MA, Pierce JH, Lombardi D, Ruggiero M, Gutkind JS, Matsui T, Aaronson SA. Deletion or substitution within the alpha platelet-derived growth factor receptor kinase insert domain: effects on functional coupling with intracellular signaling pathways. Mol Cell Biol. 1991 Jan; 11(1):134-42.
      View in: PubMed
    157. Aaronson SA, Rubin JS, Finch PW, Wong J, Marchese C, Falco J, Taylor WG, Kraus MH. Growth factor-regulated pathways in epithelial cell proliferation. Am Rev Respir Dis. 1990 Dec; 142(6 Pt 2):S7-10.
      View in: PubMed
    158. Heidaran MA, Pierce JH, Jensen RA, Matsui T, Aaronson SA. Chimeric alpha- and beta-platelet-derived growth factor (PDGF) receptors define three immunoglobulin-like domains of the alpha-PDGF receptor that determine PDGF-AA binding specificity. J Biol Chem. 1990 Nov 5; 265(31):18741-4.
      View in: PubMed
    159. McKinnon RD, Matsui T, Dubois-Dalcq M, Aaronson SA. FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron. 1990 Nov; 5(5):603-14.
      View in: PubMed
    160. Lonardo F, Di Marco E, King CR, Pierce JH, Segatto O, Aaronson SA, Di Fiore PP. The normal erbB-2 product is an atypical receptor-like tyrosine kinase with constitutive activity in the absence of ligand. New Biol. 1990 Nov; 2(11):992-1003.
      View in: PubMed
    161. Crescenzi M, Fleming TP, Lassar AB, Weintraub H, Aaronson SA. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc Natl Acad Sci U S A. 1990 Nov; 87(21):8442-6.
      View in: PubMed
    162. Giese N, LaRochelle WJ, May-Siroff M, Robbins KC, Aaronson SA. A small v-sis/platelet-derived growth factor (PDGF) B-protein domain in which subtle conformational changes abrogate PDGF receptor interaction and transforming activity. Mol Cell Biol. 1990 Oct; 10(10):5496-501.
      View in: PubMed
    163. Aaronson SA. Oncogenes and the Molecular Origins of Cancer. Robert A. Weinberg, Ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989. xii, 367 pp., illus. Paper, $55. Cold Spring Harbor Monograph 18. Science. 1990 Sep 7; 249(4973):1177-8.
      View in: PubMed
    164. Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA. Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem. 1990 Aug 5; 265(22):12767-70.
      View in: PubMed
    165. Heidaran MA, Fleming TP, Bottaro DP, Bell GI, Di Fiore PP, Aaronson SA. Transformation of NIH3T3 fibroblasts by an expression vector for the human epidermal growth factor precursor. Oncogene. 1990 Aug; 5(8):1265-70.
      View in: PubMed
    166. Marchese C, Rubin J, Ron D, Faggioni A, Torrisi MR, Messina A, Frati L, Aaronson SA. Human keratinocyte growth factor activity on proliferation and differentiation of human keratinocytes: differentiation response distinguishes KGF from EGF family. J Cell Physiol. 1990 Aug; 144(2):326-32.
      View in: PubMed
    167. Kruh GD, Perego R, Miki T, Aaronson SA. The complete coding sequence of arg defines the Abelson subfamily of cytoplasmic tyrosine kinases. Proc Natl Acad Sci U S A. 1990 Aug; 87(15):5802-6.
      View in: PubMed
    168. Aaronson SA, Pierce JH. Molecular mimicry of growth factors by products of tumor viruses. Cancer Cells. 1990 Jul; 2(7):212-4.
      View in: PubMed
    169. LaRochelle WJ, Giese N, May-Siroff M, Robbins KC, Aaronson SA. Molecular localization of the transforming and secretory properties of PDGF A and PDGF B. Science. 1990 Jun 22; 248(4962):1541-4.
      View in: PubMed
    170. Di Fiore PP, Segatto O, Lonardo F, Fazioli F, Pierce JH, Aaronson SA. The carboxy-terminal domains of erbB-2 and epidermal growth factor receptor exert different regulatory effects on intrinsic receptor tyrosine kinase function and transforming activity. Mol Cell Biol. 1990 Jun; 10(6):2749-56.
      View in: PubMed
    171. Di Fiore PP, Segatto O, Taylor WG, Aaronson SA, Pierce JH. EGF receptor and erbB-2 tyrosine kinase domains confer cell specificity for mitogenic signaling. Science. 1990 Apr 6; 248(4951):79-83.
      View in: PubMed
    172. Di Marco E, Pierce JH, Aaronson SA, Di Fiore PP. Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation. Nat Immun Cell Growth Regul. 1990; 9(3):209-21.
      View in: PubMed
    173. Larochelle WJ, Giese N, May-Siroff M, Robbins KC, Aaronson SA. Chimeric molecules map and dissociate the potent transforming and secretory properties of PDGF A and PDGF B. J Cell Sci Suppl. 1990; 13:31-42.
      View in: PubMed
    174. Melchiori A, Carlone S, Allavena G, Aresu O, Parodi S, Aaronson SA, Albini A. Invasiveness and chemotactic activity of oncogene transformed NIH/3T3 cells. Anticancer Res. 1990 Jan-Feb; 10(1):37-44.
      View in: PubMed
    175. Molloy CJ, Bottaro DP, Fleming TP, Marshall MS, Gibbs JB, Aaronson SA. PDGF induction of tyrosine phosphorylation of GTPase activating protein. Nature. 1989 Dec 7; 342(6250):711-4.
      View in: PubMed
    176. Kraus MH, Issing W, Miki T, Popescu NC, Aaronson SA. Isolation and characterization of ERBB3, a third member of the ERBB/epidermal growth factor receptor family: evidence for overexpression in a subset of human mammary tumors. Proc Natl Acad Sci U S A. 1989 Dec; 86(23):9193-7.
      View in: PubMed
    177. Miki T, Matsui T, Heidaran MA, Aaronson SA. An efficient directional cloning system to construct cDNA libraries containing full-length inserts at high frequency. Gene. 1989 Nov 15; 83(1):137-46.
      View in: PubMed
    178. Matsui T, Pierce JH, Fleming TP, Greenberger JS, LaRochelle WJ, Ruggiero M, Aaronson SA. Independent expression of human alpha or beta platelet-derived growth factor receptor cDNAs in a naive hematopoietic cell leads to functional coupling with mitogenic and chemotactic signaling pathways. Proc Natl Acad Sci U S A. 1989 Nov; 86(21):8314-8.
      View in: PubMed
    179. Fleming TP, Matsui T, Molloy CJ, Robbins KC, Aaronson SA. Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors. Proc Natl Acad Sci U S A. 1989 Oct; 86(20):8063-7.
      View in: PubMed
    180. Ron D, Graziani G, Aaronson SA, Eva A. The N-terminal region of proto-dbl down regulates its transforming activity. Oncogene. 1989 Sep; 4(9):1067-72.
      View in: PubMed
    181. Finch PW, Rubin JS, Miki T, Ron D, Aaronson SA. Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science. 1989 Aug 18; 245(4919):752-5.
      View in: PubMed
    182. LaRochelle WJ, Robbins KC, Aaronson SA. Immunochemical localization of the epitope for a monoclonal antibody that neutralizes human platelet-derived growth factor mitogenic activity. Mol Cell Biol. 1989 Aug; 9(8):3538-42.
      View in: PubMed
    183. Moscat J, Fleming TP, Molloy CJ, Lopez-Barahona M, Aaronson SA. The calcium signal for Balb/MK keratinocyte terminal differentiation induces sustained alterations in phosphoinositide metabolism without detectable protein kinase C activation. J Biol Chem. 1989 Jul 5; 264(19):11228-35.
      View in: PubMed
    184. Giese N, May-Siroff M, LaRochelle WJ, van Wyke Coelingh K, Aaronson SA. Expression and purification of biologically active v-sis/platelet-derived growth factor B protein by using a baculovirus vector system. J Virol. 1989 Jul; 63(7):3080-6.
      View in: PubMed
    185. Di Marco E, Pierce JH, Fleming TP, Kraus MH, Molloy CJ, Aaronson SA, Di Fiore PP. Autocrine interaction between TGF alpha and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene. 1989 Jul; 4(7):831-8.
      View in: PubMed
    186. Pech M, Gazit A, Arnstein P, Aaronson SA. Generation of fibrosarcomas in vivo by a retrovirus that expresses the normal B chain of platelet-derived growth factor and mimics the alternative splice pattern of the v-sis oncogene. Proc Natl Acad Sci U S A. 1989 Apr; 86(8):2693-7.
      View in: PubMed
    187. Matsui T, Heidaran M, Miki T, Popescu N, La Rochelle W, Kraus M, Pierce J, Aaronson S. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes. Science. 1989 Feb 10; 243(4892):800-4.
      View in: PubMed
    188. Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA. Purification and characterization of a newly identified growth factor specific for epithelial cells. Proc Natl Acad Sci U S A. 1989 Feb; 86(3):802-6.
      View in: PubMed
    189. Pech M, Rao CD, Robbins KC, Aaronson SA. Functional identification of regulatory elements within the promoter region of platelet-derived growth factor 2. Mol Cell Biol. 1989 Feb; 9(2):396-405.
      View in: PubMed
    190. Aaronson SA, Falco JP, Taylor WG, Cech AC, Marchese C, Finch PW, Rubin J, Weissman BE, Di Fiore PP. Pathways in which growth factors and oncogenes interact in epithelial cell mitogenic signal transduction. Ann N Y Acad Sci. 1989; 567:122-9.
      View in: PubMed
    191. Segatto O, King CR, Pierce JH, Di Fiore PP, Aaronson SA. Different structural alterations upregulate in vitro tyrosine kinase activity and transforming potency of the erbB-2 gene. Mol Cell Biol. 1988 Dec; 8(12):5570-4.
      View in: PubMed
    192. Aaronson S. Paspalum spp. and Claviceps paspali in ancient and modern India. J Ethnopharmacol. 1988 Dec; 24(2-3):345-8.
      View in: PubMed
    193. Beckmann MP, Betsholtz C, Heldin CH, Westermark B, Di Marco E, Di Fiore PP, Robbins KC, Aaronson SA. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains. Science. 1988 Sep 9; 241(4871):1346-9.
      View in: PubMed
    194. Moscat J, Molloy CJ, Fleming TP, Aaronson SA. Epidermal growth factor activates phosphoinositide turnover and protein kinase C in BALB/MK keratinocytes. Mol Endocrinol. 1988 Sep; 2(9):799-805.
      View in: PubMed
    195. Ron D, Tronick SR, Aaronson SA, Eva A. Molecular cloning and characterization of the human dbl proto-oncogene: evidence that its overexpression is sufficient to transform NIH/3T3 cells. EMBO J. 1988 Aug; 7(8):2465-73.
      View in: PubMed
    196. Blam SB, Mitchell R, Tischer E, Rubin JS, Silva M, Silver S, Fiddes JC, Abraham JA, Aaronson SA. Addition of growth hormone secretion signal to basic fibroblast growth factor results in cell transformation and secretion of aberrant forms of the protein. Oncogene. 1988 Aug; 3(2):129-36.
      View in: PubMed
    197. Kawakami T, Kawakami Y, Aaronson SA, Robbins KC. Acquisition of transforming properties by FYN, a normal SRC-related human gene. Proc Natl Acad Sci U S A. 1988 Jun; 85(11):3870-4.
      View in: PubMed
    198. Falco JP, Taylor WG, Di Fiore PP, Weissman BE, Aaronson SA. Interactions of growth factors and retroviral oncogenes with mitogenic signal transduction pathways of Balb/MK keratinocytes. Oncogene. 1988 Jun; 2(6):573-8.
      View in: PubMed
    199. Eva A, Vecchio G, Rao CD, Tronick SR, Aaronson SA. The predicted DBL oncogene product defines a distinct class of transforming proteins. Proc Natl Acad Sci U S A. 1988 Apr; 85(7):2061-5.
      View in: PubMed
    200. Pierce JH, Ruggiero M, Fleming TP, Di Fiore PP, Greenberger JS, Varticovski L, Schlessinger J, Rovera G, Aaronson SA. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science. 1988 Feb 5; 239(4840):628-31.
      View in: PubMed
    201. Di Fiore PP, Falco J, Borrello I, Weissman B, Aaronson SA. The calcium signal for BALB/MK keratinocyte terminal differentiation counteracts epidermal growth factor (EGF) very early in the EGF-induced proliferative pathway. Mol Cell Biol. 1988 Feb; 8(2):557-63.
      View in: PubMed
    202. Kraus MH, Pierce JH, Fleming TP, Robbins KC, Di Fiore PP, Aaronson SA. Mechanisms by which genes encoding growth factors and growth factor receptors contribute to malignant transformation. Ann N Y Acad Sci. 1988; 551:320-35; discussion 336.
      View in: PubMed
    203. Tronick SR, Aaronson SA. Oncogenes, growth regulation, and cancer. Adv Second Messenger Phosphoprotein Res. 1988; 21:201-14.
      View in: PubMed
    204. Kraus MH, Di Fiore PP, Pierce JH, Aaronson SA. Different mechanisms are responsible for oncogene activation in human mammary neoplasia. Cancer Treat Res. 1988; 40:49-66.
      View in: PubMed
    205. Rao CD, Pech M, Robbins KC, Aaronson SA. The 5' untranslated sequence of the c-sis/platelet-derived growth factor 2 transcript is a potent translational inhibitor. Mol Cell Biol. 1988 Jan; 8(1):284-92.
      View in: PubMed
    206. Finzi E, Kilkenny A, Strickland JE, Balaschak M, Bringman T, Derynck R, Aaronson S, Yuspa SH. TGF alpha stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression. Mol Carcinog. 1988; 1(1):7-12.
      View in: PubMed
    207. Di Fiore PP, Pierce JH, Fleming TP, Hazan R, Ullrich A, King CR, Schlessinger J, Aaronson SA. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell. 1987 Dec 24; 51(6):1063-70.
      View in: PubMed
    208. Lacal JC, Fleming TP, Warren BS, Blumberg PM, Aaronson SA. Involvement of functional protein kinase C in the mitogenic response to the H-ras oncogene product. Mol Cell Biol. 1987 Nov; 7(11):4146-9.
      View in: PubMed
    209. Lacal JC, Moscat J, Aaronson SA. Novel source of 1,2-diacylglycerol elevated in cells transformed by Ha-ras oncogene. Nature. 1987 Nov 19-25; 330(6145):269-72.
      View in: PubMed
    210. Lacal JC, de la Peña P, Moscat J, Garcia-Barreno P, Anderson PS, Aaronson SA. Rapid stimulation of diacylglycerol production in Xenopus oocytes by microinjection of H-ras p21. Science. 1987 Oct 23; 238(4826):533-6.
      View in: PubMed
    211. Reynolds SH, Stowers SJ, Patterson RM, Maronpot RR, Aaronson SA, Anderson MW. Activated oncogenes in B6C3F1 mouse liver tumors: implications for risk assessment. Science. 1987 Sep 11; 237(4820):1309-16.
      View in: PubMed
    212. Matyas GR, Aaronson SA, Brady RO, Fishman PH. Alteration of glycolipids in ras-transfected NIH 3T3 cells. Proc Natl Acad Sci U S A. 1987 Sep; 84(17):6065-8.
      View in: PubMed
    213. Di Fiore PP, Pierce JH, Kraus MH, Segatto O, King CR, Aaronson SA. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 1987 Jul 10; 237(4811):178-82.
      View in: PubMed
    214. Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, Kozlowski JM, McEwan RN. A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res. 1987 Jun 15; 47(12):3239-45.
      View in: PubMed
    215. Giese NA, Robbins KC, Aaronson SA. The role of individual cysteine residues in the structure and function of the v-sis gene product. Science. 1987 Jun 5; 236(4806):1315-8.
      View in: PubMed
    216. Finzi E, Fleming T, Segatto O, Pennington CY, Bringman TS, Derynck R, Aaronson SA. The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells. Proc Natl Acad Sci U S A. 1987 Jun; 84(11):3733-7.
      View in: PubMed
    217. Kawakami T, Sherman L, Dahlberg J, Gazit A, Yaniv A, Tronick SR, Aaronson SA. Nucleotide sequence analysis of equine infectious anemia virus proviral DNA. Virology. 1987 Jun; 158(2):300-12.
      View in: PubMed
    218. Hagag N, Lacal JC, Graber M, Aaronson S, Viola MV. Microinjection of ras p21 induces a rapid rise in intracellular pH. Mol Cell Biol. 1987 May; 7(5):1984-8.
      View in: PubMed
    219. Dahlberg JE, Mitsuya H, Blam SB, Broder S, Aaronson SA. Broad spectrum antiretroviral activity of 2',3'-dideoxynucleosides. Proc Natl Acad Sci U S A. 1987 Apr; 84(8):2469-73.
      View in: PubMed
    220. Igarashi H, Rao CD, Siroff M, Leal F, Robbins KC, Aaronson SA. Detection of PDGF-2 homodimers in human tumor cells. Oncogene. 1987 Mar; 1(1):79-85.
      View in: PubMed
    221. Eva A, Pierce JH, Aaronson SA. Interactions of retroviral and cellular transforming genes with hematopoietic cells. Ann N Y Acad Sci. 1987; 511:148-70.
      View in: PubMed
    222. Eva A, Vecchio G, Diamond M, Tronick SR, Ron D, Cooper GM, Aaronson SA. Independently activated dbl oncogenes exhibit similar yet distinct structural alterations. Oncogene. 1987; 1(4):355-60.
      View in: PubMed
    223. Kruh GD, King CR, Kraus MH, Popescu NC, Amsbaugh SC, McBride WO, Aaronson SA. A novel human gene closely related to the abl proto-oncogene. Science. 1986 Dec 19; 234(4783):1545-8.
      View in: PubMed
    224. Lacal JC, Aaronson SA. Activation of ras p21 transforming properties associated with an increase in the release rate of bound guanine nucleotide. Mol Cell Biol. 1986 Dec; 6(12):4214-20.
      View in: PubMed
    225. Srivastava SK, Wheelock RH, Aaronson SA, Eva A. Identification of the protein encoded by the human diffuse B-cell lymphoma (dbl) oncogene. Proc Natl Acad Sci U S A. 1986 Dec; 83(23):8868-72.
      View in: PubMed
    226. Pasti G, Lacal JC, Warren BS, Aaronson SA, Blumberg PM. Loss of mouse fibroblast cell response to phorbol esters restored by microinjected protein kinase C. Nature. 1986 Nov 27-Dec 3; 324(6095):375-7.
      View in: PubMed
    227. Yaniv A, Dahlberg J, Gazit A, Sherman L, Chiu IM, Tronick SR, Aaronson SA. Molecular cloning and physical characterization of integrated equine infectious anemia virus: molecular and immunologic evidence of its close relationship to ovine and caprine lentiviruses. Virology. 1986 Oct 15; 154(1):1-8.
      View in: PubMed
    228. Gazit A, Pierce JH, Kraus MH, Di Fiore PP, Pennington CY, Aaronson SA. Mammalian cell transformation by a murine retrovirus vector containing the avian erythroblastosis virus erbB gene. J Virol. 1986 Oct; 60(1):19-28.
      View in: PubMed
    229. Lacal JC, Aaronson SA. ras p21 deletion mutants and monoclonal antibodies as tools for localization of regions relevant to p21 function. Proc Natl Acad Sci U S A. 1986 Aug; 83(15):5400-4.
      View in: PubMed
    230. Pierce JH, Eva A, Aaronson SA. Interactions of oncogenes with haematopoietic cells. Clin Haematol. 1986 Aug; 15(3):573-96.
      View in: PubMed
    231. Yuasa Y, Reddy EP, Rhim JS, Tronick SR, Aaronson SA. Activated N-ras in a human rectal carcinoma cell line associated with clonal homozygosity in myb locus-restriction fragment polymorphism. Jpn J Cancer Res. 1986 Jul; 77(7):639-47.
      View in: PubMed
    232. Rhim JS, Fujita J, Arnstein P, Aaronson SA. Neoplastic conversion of human keratinocytes by adenovirus 12-SV40 virus and chemical carcinogens. Science. 1986 Apr 18; 232(4748):385-8.
      View in: PubMed
    233. Lacal JC, Aaronson SA. Monoclonal antibody Y13-259 recognizes an epitope of the p21 ras molecule not directly involved in the GTP-binding activity of the protein. Mol Cell Biol. 1986 Apr; 6(4):1002-9.
      View in: PubMed
    234. Rao CD, Igarashi H, Chiu IM, Robbins KC, Aaronson SA. Structure and sequence of the human c-sis/platelet-derived growth factor 2 (SIS/PDGF2) transcriptional unit. Proc Natl Acad Sci U S A. 1986 Apr; 83(8):2392-6.
      View in: PubMed
    235. Lacal JC, Anderson PS, Aaronson SA. Deletion mutants of Harvey ras p21 protein reveal the absolute requirement of at least two distant regions for GTP-binding and transforming activities. EMBO J. 1986 Apr; 5(4):679-87.
      View in: PubMed
    236. Needleman SW, Kraus MH, Srivastava SK, Levine PH, Aaronson SA. High frequency of N-ras activation in acute myelogenous leukemia. Blood. 1986 Mar; 67(3):753-7.
      View in: PubMed
    237. Lacal JC, Srivastava SK, Anderson PS, Aaronson SA. Ras p21 proteins with high or low GTPase activity can efficiently transform NIH/3T3 cells. Cell. 1986 Feb 28; 44(4):609-17.
      View in: PubMed
    238. Sarfeh IJ, Aaronson S, Lombino D, Rypins EB, Mason GR, Dadufalza L, Hollander D. Selective impairment of nutrient absorption from intestines with chronic venous hypertension. Surgery. 1986 Feb; 99(2):166-9.
      View in: PubMed
    239. Vecchio G, Di Fiore PP, Fusco A, Colletta G, Weissman BE, Aaronson SA. In vitro transformation of epithelial cell by acute retroviruses. Horiz Biochem Biophys. 1986; 8:415-70.
      View in: PubMed
    240. Aaronson S. A role for algae as human food in antiquity. Food Foodways. 1986; 1(3):311-5.
      View in: PubMed
    241. Aaronson SA, Igarashi H, Rao CD, Finzi E, Fleming TP, Segatto O, Robbins KC. Role of genes for normal growth factors in human malignancy. Princess Takamatsu Symp. 1986; 17:95-108.
      View in: PubMed
    242. Reynolds SH, Stowers SJ, Maronpot RR, Anderson MW, Aaronson SA. Detection and identification of activated oncogenes in spontaneously occurring benign and malignant hepatocellular tumors of the B6C3F1 mouse. Proc Natl Acad Sci U S A. 1986 Jan; 83(1):33-7.
      View in: PubMed
    243. Rao CD, Igarashi H, Pech MW, Robbins KC, Aaronson SA. Oncogenic potential of the human platelet-derived growth factor transcriptional unit. Cold Spring Harb Symp Quant Biol. 1986; 51 Pt 2:959-66.
      View in: PubMed
    244. Pierce JH, Gazit A, Di Fiore PP, Kraus M, Pennington CY, Holmes KL, Davidson WF, Morse HC, Aaronson SA. Mammalian cell transformation by a recombinant murine retrovirus containing the avian erythroblastosis virus erbB gene. Curr Top Microbiol Immunol. 1986; 132:55-61.
      View in: PubMed
    245. Robbins KC, King CR, Giese NA, Leal F, Igarashi H, Aaronson SA. Involvement of oncogene-coded growth factors in the neoplastic process. Gene Amplif Anal. 1986; 4:161-76.
      View in: PubMed
    246. King CR, Kraus MH, Williams LT, Merlino GT, Pastan IH, Aaronson SA. Human tumor cell lines with EGF receptor gene amplification in the absence of aberrant sized mRNAs. Nucleic Acids Res. 1985 Dec 9; 13(23):8477-86.
      View in: PubMed
    247. Weissman B, Aaronson SA. Members of the src and ras oncogene families supplant the epidermal growth factor requirement of BALB/MK-2 keratinocytes and induce distinct alterations in their terminal differentiation program. Mol Cell Biol. 1985 Dec; 5(12):3386-96.
      View in: PubMed
    248. Srivastava SK, Lacal JC, Reynolds SH, Aaronson SA. Antibody of predetermined specificity to a carboxy-terminal region of H-ras gene products inhibits their guanine nucleotide-binding function. Mol Cell Biol. 1985 Nov; 5(11):3316-9.
      View in: PubMed
    249. Leal F, Williams LT, Robbins KC, Aaronson SA. Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor. Science. 1985 Oct 18; 230(4723):327-30.
      View in: PubMed
    250. King CR, Kraus MH, Aaronson SA. Amplification of a novel v-erbB-related gene in a human mammary carcinoma. Science. 1985 Sep 6; 229(4717):974-6.
      View in: PubMed
    251. Yaniv A, Dahlberg JE, Tronick SR, Chiu IM, Aaronson SA. Molecular cloning of integrated caprine arthritis-encephalitis virus. Virology. 1985 Sep; 145(2):340-5.
      View in: PubMed
    252. Chiu IM, Yaniv A, Dahlberg JE, Gazit A, Skuntz SF, Tronick SR, Aaronson SA. Nucleotide sequence evidence for relationship of AIDS retrovirus to lentiviruses. Nature. 1985 Sep 26-Oct 2; 317(6035):366-8.
      View in: PubMed
    253. King CR, Giese NA, Robbins KC, Aaronson SA. In vitro mutagenesis of the v-sis transforming gene defines functional domains of its growth factor-related product. Proc Natl Acad Sci U S A. 1985 Aug; 82(16):5295-9.
      View in: PubMed
    254. Robbins KC, Leal F, Pierce JH, Aaronson SA. The v-sis/PDGF-2 transforming gene product localizes to cell membranes but is not a secretory protein. EMBO J. 1985 Jul; 4(7):1783-92.
      View in: PubMed
    255. Eva A, Aaronson SA. Isolation of a new human oncogene from a diffuse B-cell lymphoma. Nature. 1985 Jul 18-24; 316(6025):273-5.
      View in: PubMed
    256. Pierce JH, Di Fiore PP, Aaronson SA, Potter M, Pumphrey J, Scott A, Ihle JN. Neoplastic transformation of mast cells by Abelson-MuLV: abrogation of IL-3 dependence by a nonautocrine mechanism. Cell. 1985 Jul; 41(3):685-93.
      View in: PubMed
    257. Chiu IM, Huang RC, Aaronson SA. Genetic relatedness between intracisternal A particles and other major oncovirus genera. Virus Res. 1985 Jul; 3(1):1-11.
      View in: PubMed
    258. Callahan R, Chiu IM, Wong JF, Tronick SR, Roe BA, Aaronson SA, Schlom J. A new class of endogenous human retroviral genomes. Science. 1985 Jun 7; 228(4704):1208-11.
      View in: PubMed
    259. Fujita J, Srivastava SK, Kraus MH, Rhim JS, Tronick SR, Aaronson SA. Frequency of molecular alterations affecting ras protooncogenes in human urinary tract tumors. Proc Natl Acad Sci U S A. 1985 Jun; 82(11):3849-53.
      View in: PubMed
    260. Pierce JH, Aaronson SA. Myeloid cell transformation by ras-containing murine sarcoma viruses. Mol Cell Biol. 1985 Apr; 5(4):667-74.
      View in: PubMed
    261. Rhim JS, Jay G, Arnstein P, Price FM, Sanford KK, Aaronson SA. Neoplastic transformation of human epidermal keratinocytes by AD12-SV40 and Kirsten sarcoma viruses. Science. 1985 Mar 8; 227(4691):1250-2.
      View in: PubMed
    262. Reddy EP, Lipman D, Andersen PR, Tronick SR, Aaronson SA. Nucleotide sequence analysis of the BALB/c murine sarcoma virus transforming gene. J Virol. 1985 Mar; 53(3):984-7.
      View in: PubMed
    263. Popescu NC, Amsbaugh SC, DiPaolo JA, Tronick SR, Aaronson SA, Swan DC. Chromosomal localization of three human ras genes by in situ molecular hybridization. Somat Cell Mol Genet. 1985 Mar; 11(2):149-55.
      View in: PubMed
    264. Rhim JS, Sanford KK, Arnstein P, Fujita J, Jay G, Aaronson SA. Human epithelial cell carcinogenesis: combined action of DNA and RNA tumor viruses produces malignant transformation of primary human epidermal keratinocytes. Carcinog Compr Surv. 1985; 9:57-66.
      View in: PubMed
    265. Aaronson SA, Tronick SR. Transforming genes of human malignancies. Carcinog Compr Surv. 1985; 10:35-49.
      View in: PubMed
    266. Aaronson SA, Tronick SR. The role of oncogenes in human neoplasia. Important Adv Oncol. 1985; 3-15.
      View in: PubMed
    267. Srivastava SK, Yuasa Y, Reynolds SH, Aaronson SA. Effects of two major activating lesions on the structure and conformation of human ras oncogene products. Proc Natl Acad Sci U S A. 1985 Jan; 82(1):38-42.
      View in: PubMed
    268. Balachandran R, Reddy EP, Dunn CY, Aaronson SA, Swan DC. Immunoglobulin synthesis and gene rearrangements in lymphoid cells transformed by replication-competent Rauscher murine leukemia virus: transformation of B cells at various stages of differentiation. EMBO J. 1984 Dec 20; 3(13):3199-207.
      View in: PubMed
    269. Gazit A, Igarashi H, Chiu IM, Srinivasan A, Yaniv A, Tronick SR, Robbins KC, Aaronson SA. Expression of the normal human sis/PDGF-2 coding sequence induces cellular transformation. Cell. 1984 Nov; 39(1):89-97.
      View in: PubMed
    270. Kraus MH, Yuasa Y, Aaronson SA. A position 12-activated H-ras oncogene in all HS578T mammary carcinosarcoma cells but not normal mammary cells of the same patient. Proc Natl Acad Sci U S A. 1984 Sep; 81(17):5384-8.
      View in: PubMed
    271. Narayanan R, Srinivasan A, Aaronson SA. Sequences in the long terminal repeats of the Moloney murine sarcoma virus-124 genome which control transforming gene function. Virology. 1984 Aug; 137(1):32-40.
      View in: PubMed
    272. Yuasa Y, Gol RA, Chang A, Chiu IM, Reddy EP, Tronick SR, Aaronson SA. Mechanism of activation of an N-ras oncogene of SW-1271 human lung carcinoma cells. Proc Natl Acad Sci U S A. 1984 Jun; 81(12):3670-4.
      View in: PubMed
    273. Chiu IM, Reddy EP, Givol D, Robbins KC, Tronick SR, Aaronson SA. Nucleotide sequence analysis identifies the human c-sis proto-oncogene as a structural gene for platelet-derived growth factor. Cell. 1984 May; 37(1):123-9.
      View in: PubMed
    274. Fujita J, Yoshida O, Yuasa Y, Rhim JS, Hatanaka M, Aaronson SA. Ha-ras oncogenes are activated by somatic alterations in human urinary tract tumours. Nature. 1984 May 31-Jun 6; 309(5967):464-6.
      View in: PubMed
    275. Pierce JH, Aaronson SA, Anderson SM. Hematopoietic cell transformation by a murine recombinant retrovirus containing the src gene of Rous sarcoma virus. Proc Natl Acad Sci U S A. 1984 Apr; 81(8):2374-8.
      View in: PubMed
    276. Chiu IM, Callahan R, Tronick SR, Schlom J, Aaronson SA. Major pol gene progenitors in the evolution of oncoviruses. Science. 1984 Jan 27; 223(4634):364-70.
      View in: PubMed
    277. Srinivasan A, Reddy EP, Dunn CY, Aaronson SA. Molecular dissection of transcriptional control elements within the long terminal repeat of the retrovirus. Science. 1984 Jan 20; 223(4633):286-9.
      View in: PubMed
    278. Devare SG, Shatzman A, Robbins KC, Rosenberg M, Aaronson SA. Expression of the PDGF-related transforming protein of simian sarcoma virus in E. coli. Cell. 1984 Jan; 36(1):43-9.
      View in: PubMed
    279. Aaronson SA, Robbins KC, Tronick SR. Human proto-oncogenes, growth factors, and cancer. Symp Fundam Cancer Res. 1984; 37:241-55.
      View in: PubMed
    280. Tronick SR, Yuasa Y, Robbins KC, Eva A, Gol R, Aaronson SA. Oncogene research: closing in on a better understanding of cancer causation. Ann N Y Acad Sci. 1984; 437:150-60.
      View in: PubMed
    281. Pierce JH, Aaronson SA. Interaction of acute transforming retroviruses with murine hematopoietic cells. Curr Top Microbiol Immunol. 1984; 113:258-64.
      View in: PubMed
    282. McBride OW, Swan DC, Tronick SR, Gol R, Klimanis D, Moore DE, Aaronson SA. Regional chromosomal localization of N-ras, K-ras-1, K-ras-2 and myb oncogenes in human cells. Nucleic Acids Res. 1983 Dec 10; 11(23):8221-36.
      View in: PubMed
    283. Needleman SW, Yuasa Y, Srivastava S, Aaronson SA. Normal cells of patients with high cancer risk syndromes lack transforming activity in the NIH/3T3 transfection assay. Science. 1983 Oct 14; 222(4620):173-5.
      View in: PubMed
    284. Cohen BE, Aaronson S. Microvascular reconstructive surgery: free tissue transfer. AORN J. 1983 Oct; 38(4):602-9.
      View in: PubMed
    285. Robbins KC, Antoniades HN, Devare SG, Hunkapiller MW, Aaronson SA. Structural and immunological similarities between simian sarcoma virus gene product(s) and human platelet-derived growth factor. Nature. 1983 Oct 13-19; 305(5935):605-8.
      View in: PubMed
    286. Chiu IM, Andersen PR, Aaronson SA, Tronick SR. Molecular cloning of the unintegrated squirrel monkey retrovirus genome: organization and distribution of related sequences in primate DNAs. J Virol. 1983 Sep; 47(3):434-41.
      View in: PubMed
    287. Naharro G, Tronick SR, Rasheed S, Gardner MB, Aaronson SA, Robbins KC. Molecular cloning of integrated Gardner-Rasheed feline sarcoma virus: genetic structure of its cell-derived sequence differs from that of other tyrosine kinase-coding onc genes. J Virol. 1983 Sep; 47(3):611-9.
      View in: PubMed
    288. Eva A, Tronick SR, Gol RA, Pierce JH, Aaronson SA. Transforming genes of human hematopoietic tumors: frequent detection of ras-related oncogenes whose activation appears to be independent of tumor phenotype. Proc Natl Acad Sci U S A. 1983 Aug; 80(16):4926-30.
      View in: PubMed
    289. Doolittle RF, Hunkapiller MW, Hood LE, Devare SG, Robbins KC, Aaronson SA, Antoniades HN. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. Science. 1983 Jul 15; 221(4607):275-7.
      View in: PubMed
    290. Yuasa Y, Srivastava SK, Dunn CY, Rhim JS, Reddy EP, Aaronson SA. Acquisition of transforming properties by alternative point mutations within c-bas/has human proto-oncogene. Nature. 1983 Jun 30; 303(5920):775-9.
      View in: PubMed
    291. Pierce JH, Aaronson SA. In vitro transformation of murine pre-B lymphoid cells by Snyder-Theilen feline sarcoma virus. J Virol. 1983 Jun; 46(3):993-1002.
      View in: PubMed
    292. Eva A, Aaronson SA. Frequent activation of c-kis as a transforming gene in fibrosarcomas induced by methylcholanthrene. Science. 1983 May 27; 220(4600):955-6.
      View in: PubMed
    293. Devare SG, Reddy EP, Law JD, Robbins KC, Aaronson SA. Nucleotide sequence of the simian sarcoma virus genome: demonstration that its acquired cellular sequences encode the transforming gene product p28sis. Proc Natl Acad Sci U S A. 1983 Feb; 80(3):731-5.
      View in: PubMed
    294. Weissman BE, Aaronson SA. BALB and Kirsten murine sarcoma viruses alter growth and differentiation of EGF-dependent balb/c mouse epidermal keratinocyte lines. Cell. 1983 Feb; 32(2):599-606.
      View in: PubMed
    295. Aaronson SA, Dunn CY, Ellmore NW, Eva A. Retroviral onc genes in human neoplasia. Prog Clin Biol Res. 1983; 119:207-22.
      View in: PubMed
    296. Aaronson SA. Unique aspects of the interactions of retroviruses with vertebrate cells: C. P. Rhoads memorial lecture. Cancer Res. 1983 Jan; 43(1):1-5.
      View in: PubMed
    297. McBride OW, Swan DC, Santos E, Barbacid M, Tronick SR, Aaronson SA. Localization of the normal allele of T24 human bladder carcinoma oncogene to chromosome 11. Nature. 1982 Dec 23; 300(5894):773-4.
      View in: PubMed
    298. Robbins KC, Devare SG, Reddy EP, Aaronson SA. In vivo identification of the transforming gene product of simian sarcoma virus. Science. 1982 Dec 10; 218(4577):1131-3.
      View in: PubMed
    299. Pulciani S, Santos E, Lauver AV, Long LK, Aaronson SA, Barbacid M. Oncogenes in solid human tumours. Nature. 1982 Dec 9; 300(5892):539-42.
      View in: PubMed
    300. Taub R, Kirsch I, Morton C, Lenoir G, Swan D, Tronick S, Aaronson S, Leder P. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A. 1982 Dec; 79(24):7837-41.
      View in: PubMed
    301. Merregaert J, Aaronson SA. Characterization of inducible type-C RNA viruses of mouse strains from different geographic areas. Virology. 1982 Nov; 123(1):165-74.
      View in: PubMed
    302. Habara A, Reddy EP, Aaronson SA. Rauscher murine leukemia virus: molecular cloning of infectious integrated proviral DNA. J Virol. 1982 Nov; 44(2):731-5.
      View in: PubMed
    303. Prakash K, McBride OW, Swan DC, Devare SG, Tronick SR, Aaronson SA. Molecular cloning and chromosomal mapping of a human locus related to the transforming gene of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A. 1982 Sep; 79(17):5210-4.
      View in: PubMed
    304. Pierce JH, Aaronson SA. BALB- and Harvey-murine sarcoma virus transformation of a novel lymphoid progenitor cell. J Exp Med. 1982 Sep 1; 156(3):873-87.
      View in: PubMed
    305. Srinivasan A, Dunn CY, Yuasa Y, Devare SG, Reddy EP, Aaronson SA. Abelson murine leukemia virus: structural requirements for transforming gene function. Proc Natl Acad Sci U S A. 1982 Sep; 79(18):5508-12.
      View in: PubMed
    306. Swan DC, McBride OW, Robbins KC, Keithley DA, Reddy EP, Aaronson SA. Chromosomal mapping of the simian sarcoma virus onc gene analogue in human cells. Proc Natl Acad Sci U S A. 1982 Aug; 79(15):4691-5.
      View in: PubMed
    307. Santos E, Tronick SR, Aaronson SA, Pulciani S, Barbacid M. T24 human bladder carcinoma oncogene is an activated form of the normal human homologue of BALB- and Harvey-MSV transforming genes. Nature. 1982 Jul 22; 298(5872):343-7.
      View in: PubMed
    308. Devare SG, Reddy EP, Law JD, Aaronson SA. Nucleotide sequence analysis of the long terminal repeat of integrated simian sarcoma virus: evolutionary relationship with other mammalian retroviral long terminal repeats. J Virol. 1982 Jun; 42(3):1108-13.
      View in: PubMed
    309. Devare SG, Reddy EP, Robbins KC, Andersen PR, Tronick SR, Aaronson SA. Nucleotide sequence of the transforming gene of simian sarcoma virus. Proc Natl Acad Sci U S A. 1982 May; 79(10):3179-82.
      View in: PubMed
    310. Westin EH, Wong-Staal F, Gelmann EP, Dalla-Favera R, Papas TS, Lautenberger JA, Eva A, Reddy EP, Tronick SR, Aaronson SA, Gallo RC. Expression of cellular homologues of retroviral onc genes in human hematopoietic cells. Proc Natl Acad Sci U S A. 1982 Apr; 79(8):2490-4.
      View in: PubMed
    311. Westin EH, Gallo RC, Arya SK, Eva A, Souza LM, Baluda MA, Aaronson SA, Wong-Staal F. Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci U S A. 1982 Apr; 79(7):2194-8.
      View in: PubMed
    312. Rasheed S, Barbacid M, Aaronson S, Gardner MB. Origin and biological properties of a new feline sarcoma virus. Virology. 1982 Feb; 117(1):238-44.
      View in: PubMed
    313. Robbins KC, Hill RL, Aaronson SA. Primate origin of the cell-derived sequences of simian sarcoma virus. J Virol. 1982 Feb; 41(2):721-5.
      View in: PubMed
    314. Eva A, Robbins KC, Andersen PR, Srinivasan A, Tronick SR, Reddy EP, Ellmore NW, Galen AT, Lautenberger JA, Papas TS, Westin EH, Wong-Staal F, Gallo RC, Aaronson SA. Cellular genes analogous to retroviral onc genes are transcribed in human tumour cells. Nature. 1982 Jan 14; 295(5845):116-9.
      View in: PubMed
    315. Aaronson S, Dubinsky Z. Mass production of microalgae. Experientia Suppl. 1982; 43:42-6.
      View in: PubMed
    316. Andersen PR, Tronick SR, Aaronson SA. Structural organization and biological activity of molecular clones of the integrated genome of a BALB/c mouse sarcoma virus. J Virol. 1981 Nov; 40(2):431-9.
      View in: PubMed
    317. Reddy EP, Smith MJ, Aaronson SA. Complete nucleotide sequence and organization of the Moloney murine sarcoma virus genome. Science. 1981 Oct 23; 214(4519):445-50.
      View in: PubMed
    318. Andersen PR, Devare SG, Tronick SR, Ellis RW, Aaronson SA, Scolnick EM. Generation of BALB-MuSV and Ha-MuSC by type C virus transduction of homologous transforming genes from different species. Cell. 1981 Oct; 26(1 Pt 1):129-34.
      View in: PubMed
    319. Oroszlan S, Barbacid M, Copeland TD, Aaronson SA, Gilden RV. Chemical and Immunological characterization of the major structural protein (p28) of MMC-1, a rhesus monkey endogenous type C virus: homology with the major structural protein of avian reticuloendotheliosis virus. J Virol. 1981 Sep; 39(3):845-54.
      View in: PubMed
    320. Merregaert J, Barbacid M, Aaronson SA. Recombinants between temperature-sensitive mutants of rauscher murine leukemia virus and BALB:virus-2: genetic mapping of the Rauscher murine leukemia virus genome. J Virol. 1981 Jul; 39(1):219-28.
      View in: PubMed
    321. Robbins KC, Devare SG, Aaronson SA. Molecular cloning of integrated simian sarcoma virus: genome organization of infectious DNA clones. Proc Natl Acad Sci U S A. 1981 May; 78(5):2918-22.
      View in: PubMed
    322. Cremer K, Reddy EP, Aaronson SA. Translational products of Moloney murine sarcoma virus RNA: identification of proteins encoded by the murine sarcoma virus src gene. J Virol. 1981 May; 38(2):704-11.
      View in: PubMed
    323. Nagao K, Yokoro K, Aaronson SA. Continuous lines of basophil/mast cells derived from normal mouse bone marrow. Science. 1981 Apr 17; 212(4492):333-5.
      View in: PubMed
    324. Srinivasan A, Reddy EP, Aaronson SA. Abelson murine leukemia virus: molecular cloning of infectious integrated proviral DNA. Proc Natl Acad Sci U S A. 1981 Apr; 78(4):2077-81.
      View in: PubMed
    325. Aaronson SA, Barbacid M, Dunn CY, Reddy EP. Genetic approaches toward elucidating the mechanisms of type-C virus-induced leukemia. Haematol Blood Transfus. 1981; 26:455-9.
      View in: PubMed
    326. Calhoon RE, Aaronson S. Evidence for affinities among major taxa from the analysis of amino acid frequencies in glycoproteins from cell surface structures. Ann N Y Acad Sci. 1981; 361:472-80.
      View in: PubMed
    327. Reddy EP, Smith MJ, Canaani E, Robbins KC, Tronick SR, Zain S, Aaronson SA. Nucleotide sequence analysis of the transforming region and large terminal redundancies of Moloney murine sarcoma virus. Proc Natl Acad Sci U S A. 1980 Sep; 77(9):5234-8.
      View in: PubMed
    328. Canaani E, Aaronson SA. Isolation and characterization of naturally occuring deletion mutants of Moloney murine sarcoma virus. Virology. 1980 Sep; 105(2):456-66.
      View in: PubMed
    329. Rosen SW, Kaminska J, Calvert IS, Ellmore N, Aaronson SA. Ectopic production of "pregnancy-specific" beta-1 glycoprotein in vitro: discordance with three other placental proteins. Am J Obstet Gynecol. 1980 Jul 1; 137(5):525-9.
      View in: PubMed
    330. Rosen SW, Weintraub BD, Aaronson SA. Nonrandom ectopic protein production by malignant cells: direct evidence in vitro. J Clin Endocrinol Metab. 1980 May; 50(5):834-41.
      View in: PubMed
    331. Barbacid M, Bolognesi D, Aaronson SA. Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus. Proc Natl Acad Sci U S A. 1980 Mar; 77(3):1617-21.
      View in: PubMed
    332. Reddy EP, Dunn CY, Aaronson SA. Different lymphoid cell targets by transformation by replication-competent Moloney and Rauscher mouse leukemia viruses. Cell. 1980 Mar; 19(3):663-9.
      View in: PubMed
    333. Aaronson SA, Barbacid M. Viral genes involved in leukemogenesis. I. Generation of recombinants between oncogenic and nononcogenic mouse type-C viruses in tissue culture. J Exp Med. 1980 Feb 1; 151(2):467-80.
      View in: PubMed
    334. Barbacid M, Long LK, Aaronson SA. Major structural proteins of type B, type C, and type D oncoviruses share interspecies antigenic determinants. Proc Natl Acad Sci U S A. 1980 Jan; 77(1):72-6.
      View in: PubMed
    335. Barbacid M, Daniel MD, Aaronson SA. Immunological relationships of OMC-1, an endogenous virus of owl monkeys, with mammalian and avian type C viruses. J Virol. 1980 Jan; 33(1):561-6.
      View in: PubMed
    336. Dahlberg JE, Tronick SR, Aaronson SA. Immunological relationships of an endogenous guinea pig retrovirus with prototype mammalian type B and type D retroviruses. J Virol. 1980 Jan; 33(1):522-30.
      View in: PubMed
    337. Canaani E, Tronick SR, Robbins KC, Andersen PR, Dunn CY, Aaronson SA. Cellular origin of the transforming gene of Moloney murine sarcoma virus. Cold Spring Harb Symp Quant Biol. 1980; 44 Pt 2,:727-34.
      View in: PubMed
    338. Tronick SR, Robbins KC, Canaani E, Devare SG, Andersen PR, Aaronson SA. Molecular cloning of Moloney murine sarcoma virus: arrangement of virus-related sequences within the normal mouse genome. Proc Natl Acad Sci U S A. 1979 Dec; 76(12):6314-8.
      View in: PubMed
    339. Canaani E, Robbins KC, Aaronson SA. The transforming gene of Moloney murine sarcoma virus. Nature. 1979 Nov 22; 282(5737):378-83.
      View in: PubMed
    340. Rosen SW, Kaminska J, Calvert IS, Aaronson SA. Human fibroblasts produce "pregnancy-specific" beta-1 glycoprotein in vitro. Am J Obstet Gynecol. 1979 Aug 1; 134(7):734-8.
      View in: PubMed
    341. Robbins KC, Barbacid M, Porzig KJ, Aaronson SA. Involvement of different exogenous feline leukemia virus subgroups in the generation of independent feline sarcoma virus isolates. Virology. 1979 Aug; 97(1):1-11.
      View in: PubMed
    342. Frankel AE, Gilbert JH, Porzig KJ, Scolnick EM, Aaronson SA. Nature and distribution of feline sarcoma virus nucleotide sequences. J Virol. 1979 Jun; 30(3):821-7.
      View in: PubMed
    343. Calhoon RE, Aaronson S. A discriminant analysis of amino acid frequency in collagen-like proteins. J Theor Biol. 1979 May 21; 78(2):225-39.
      View in: PubMed
    344. Barbacid M, Hunter E, Aaronson SA. Avian reticuloendotheliosis viruses: evolutionary linkage with mammalian type C retroviruses. J Virol. 1979 May; 30(2):508-14.
      View in: PubMed
    345. Andersen PR, Barbacid M, Tronick SR, Clark HF, Aaronson SA. Evolutionary relatedness of viper and primate endogenous retroviruses. Science. 1979 Apr 20; 204(4390):318-21.
      View in: PubMed
    346. Canaani E, Aaronson SA. Restriction enzyme analysis of mouse cellular type C viral DNA: emergence of new viral sequences in spontaneous AKR/J lymphomas. Proc Natl Acad Sci U S A. 1979 Apr; 76(4):1677-81.
      View in: PubMed
    347. Porzig KJ, Robbins KC, Aaronson SA. Cellular regulation of mammalian sarcoma virus expression: a gene regulation model for oncogenesis. Cell. 1979 Apr; 16(4):875-84.
      View in: PubMed
    348. Porzig KJ, Barbacid M, Aaronson SA. Biological properties and translational products of three independent isolates of feline sarcoma virus. Virology. 1979 Jan 15; 92(1):91-107.
      View in: PubMed
    349. Barbacid M, Robbins KC, Aaronson SA. Wild mouse RNA tumor viruses. A nongenetically transmitted virus group closely related to exogenous leukemia viruses of laboratory mouse strains. J Exp Med. 1979 Jan 1; 149(1):254-66.
      View in: PubMed
    350. Krakower JM, Tronick SR, Gallagher RE, Gallo RC, Aaronson SA. Antigenic characterization of a new gibbon ape leukemia virus isolate: seroepidemiologic assessment of an outbreak of gibbon leukemia. Int J Cancer. 1978 Dec; 22(6):715-20.
      View in: PubMed
    351. Israel MA, Martin MA, Takemoto KK, Howley PM, Aaronson SA, Solomon D, Khoury G. Evaluation of normal and neoplastic human tissue for BK virus. Virology. 1978 Oct 15; 90(2):187-96.
      View in: PubMed
    352. Lai MH, Verma IM, Tronick SR, Aaronson SA. Mammalian retrovirus-associated RNase H is virus coded. J Virol. 1978 Sep; 27(3):823-5.
      View in: PubMed
    353. Barbacid M, Troxler DH, Scolnick EM, Aaronson SA. Analysis of translational products of Friend strain of spleen focus-forming virus. J Virol. 1978 Sep; 27(3):826-30.
      View in: PubMed
    354. Aaronson S, Rostan R. Addition of a pontic to a preexisting fixed bridge. Dent Surv. 1978 Aug; 54(8):40-1.
      View in: PubMed
    355. Aaronson SA, Barbacid M. Origin and biological properties of a new BALB/c mouse sarcoma virus. J Virol. 1978 Aug; 27(2):366-73.
      View in: PubMed
    356. Krakower JM, Aaronson SA. Seroepidemiologic assessment of feline leukaemia virus infection risk for man. Nature. 1978 Jun 8; 273(5662):463-4.
      View in: PubMed
    357. Tronick SR, Cabradilla CD, Aaronson SA, Haseltine WA. 5'-terminal nucleotide sequences of mammalian type C helper viruses are conserved in the genomes of replication-defective mammalian transforming viruses. J Virol. 1978 Jun; 26(3):570-6.
      View in: PubMed
    358. Aaronson SA, Krakower JM, Tronick SR, Stephenson JR. Immunologic approaches toward detection of type C viral expression in man. Arthritis Rheum. 1978 Jun; 21(5 Suppl):S27-45.
      View in: PubMed
    359. Krakower JM, Aaronson SA. Radioimmunologic characterization of RD-114 reverse transcriptase: evolutionary relatedness of mammalian type C viral pol gene products. Virology. 1978 May 1; 86(1):127-37.
      View in: PubMed
    360. Barbacid M, Aaronson SA. Membrane properties of the gag gene-coded p15 protein of mouse type-C RNA tumor viruses. J Biol Chem. 1978 Mar 10; 253(5):1408-14.
      View in: PubMed
    361. Kahan D, Oren R, Aaronson S, Behrens U. Fine structure of the cell surface and Golgi apparatus of Ochromonas. J Protozool. 1978 Feb; 25(1):30-3.
      View in: PubMed
    362. Barbacid M, Robbins KC, Hino S, Aaronson SA. Genetic recombination between mouse type C RNA viruses: a mechanism for endogenous viral gene amplification in mammalian cells. Proc Natl Acad Sci U S A. 1978 Feb; 75(2):923-7.
      View in: PubMed
    363. Robbins KC, Okabe H, Tronick SR, Gilden RV, Aaronson SA. Molecular mechanisms involved in the differential expression of gag gene products by clonal isolates of a primate sarcoma virus. J Virol. 1978 Feb; 25(2):471-8.
      View in: PubMed
    364. Barbacid M, Tronick SR, Aaronson SA. Isolation and characterization of an endogenous type C RNA virus of mink (Mv1Lu) cells. J Virol. 1978 Jan; 25(1):129-37.
      View in: PubMed
    365. Hino S, Tronick SR, Heberling RL, Kalter SS, Hellman A, Aaronson SA. Endogenous New World primate retrovirus: interspecies antigenic determinants shared with the major structural protein of type-D RNA viruses of Old World monkeys. Proc Natl Acad Sci U S A. 1977 Dec; 74(12):5734-8.
      View in: PubMed
    366. Robbins KC, Stephenson JR, Cabradilla CD, Aaronson SA. Endogenous mouse type-C RNA virus of SWR cells: inducibility locus containing structural information for a new endogenous virus class. Virology. 1977 Oct 15; 82(2):392-400.
      View in: PubMed
    367. Krakower JM, Barbacid M, Aaronson SA. Differential synthesis of mammalian type C viral gene products in infected cells. J Virol. 1977 Oct; 24(1):1-7.
      View in: PubMed
    368. Patni NJ, Aaronson S. Stimulation of acid phosphatase secretion in a lower eukaryote, Ochromonas danica, by specific organic phosphates. Biochim Biophys Acta. 1977 Sep 20; 478(2):209-14.
      View in: PubMed
    369. Tronick SR, Golub MM, Stephenson JR, Aaronson SA. Distribution and expression in mammals of genes ralated to an endogenous type C RNA virus of Odocoileus hemionus. J Virol. 1977 Jul; 23(1):1-9.
      View in: PubMed
    370. Reynolds FH, Hanson CA, Aaronson SA, Stephenson JR. Type C viral gag gene expression in chicken embryo fibroblasts and avian sarcoma virus-transformed mammalian cells. J Virol. 1977 Jul; 23(1):74-9.
      View in: PubMed
    371. Robbins KC, Cabradilla CD, Stephenson JR, Aaronson SA. Segregation of genetic information for a B-tropic leukemia virus with the structural locus for BALB:virus-1. Proc Natl Acad Sci U S A. 1977 Jul; 74(7):2953-7.
      View in: PubMed
    372. Krakower JM, Barbacid M, Aaronson SA. Radioimmunoassay for mammalian type C viral reverse transcriptase. J Virol. 1977 May; 22(2):331-9.
      View in: PubMed
    373. Bensinger WI, Robbins KC, Greenberger JS, Aaronson SA. Different mechanisms for morphologic reversion of a clonal population of murine sarcoma virus-transformed nonproducer cells. Virology. 1977 Apr; 77(2):750-61.
      View in: PubMed
    374. Patni NJ, Dhawale SW, Aaronson S. Extracellular phosphatases of Chlamydomonas reinhardi and their regulation. J Bacteriol. 1977 Apr; 130(1):205-11.
      View in: PubMed
    375. Peters RL, Sass B, Stephenson JR, Al-Ghazzouli IK, Hino S, Donahoe RM, Kende M, Aaronson SA, KElloff GJ. Immunoprevention of x-ray-induced leukemias in the C57BL mouse. Proc Natl Acad Sci U S A. 1977 Apr; 74(4):1697-701.
      View in: PubMed
    376. Barbacid M, Stephenson JR, Aaronson SA. Evolutionary relationships between gag gene-coded proteins of murine and primate endogenous type C RNA viruses. Cell. 1977 Apr; 10(4):641-8.
      View in: PubMed
    377. Stephenson JR, Aaronson SA. Endogenous C-type viral expression in primates. Nature. 1977 Mar 31; 266(5601):469-72.
      View in: PubMed
    378. Stephenson JR, Essex M, Hino S, Hardy WD, Aaronson SA. Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Proc Natl Acad Sci U S A. 1977 Mar; 74(3):1219-23.
      View in: PubMed
    379. Aaronson S, Dhawale SW, Patni NJ, DeAngelis B, Frank O, Baker H. The cell content and secretion of water-soluble vitamins by several freshwater algae. Arch Microbiol. 1977 Feb 4; 112(1):57-9.
      View in: PubMed
    380. Phillips SM, Stephenson JR, Aaronson SA. Genetic factors infuencing mouse type-C RNA virus induction by naturally occurring B cell mitogens. J Immunol. 1977 Feb; 118(2):662-6.
      View in: PubMed
    381. Aaronson SA, Stephenson JR. Intracellular and systemic regulation of biologically distinguishable endogenous type C RNA viruses of mouse cells. Contemp Top Immunobiol. 1977; 6:107-26.
      View in: PubMed
    382. Aaronson S. Restoration of an incompletely erupted cuspid with a combination of composite materials: report of case. J Am Dent Assoc. 1977 Jan; 94(1):114-5.
      View in: PubMed
    383. Essex M, Cotter SM, Sliski AH, Hardy WD, Stephenson JR, Aaronson SA, Jarrett O. Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Int J Cancer. 1977 Jan; 19(1):90-6.
      View in: PubMed
    384. Devare SG, Stephenson JR, Sarma PS, Aaronson SA, Charder S. Bovine lymphosarcoma: development of a radioimmunologic technique for detection of the etiologic agent. Science. 1976 Dec 24; 194(4272):1428-30.
      View in: PubMed
    385. Aaronson SA, Stephenson JR. Endogenous type-C RNA viruses of mammalian cells. Biochim Biophys Acta. 1976 Dec 23; 458(4):323-54.
      View in: PubMed
    386. Cabradilla CD, Robbins KC, Aaronson SA. Induction of mouse type-C virus by translational inhibitors: evidence for transcriptional derepression of a specific class of endogenous virus. Proc Natl Acad Sci U S A. 1976 Dec; 73(12):4541-5.
      View in: PubMed
    387. Aaronson SA, Tronick SR, Stephenson JR. Endogenous type C RNA virus of Odocoileus hemionus, a mammalian species of New World origin. Cell. 1976 Nov; 9(3):489-94.
      View in: PubMed
    388. Stephenson JR, Peters RL, Hino S, Donahoe RM, Long LK, Aaronson SA, Kelloff GJ. Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses. J Virol. 1976 Sep; 19(3):890-8.
      View in: PubMed
    389. Barbacid M, Stephenson JR, Aaronson SA. Structural polypeptides of mammalian type C RNA viruses. Isolation and immunologic characterization of a low molecular weight polypeptide, p10. J Biol Chem. 1976 Aug 25; 251(16):4859-66.
      View in: PubMed
    390. Barbacid M, Stephenson JR, Aaronson SA. gag Gene of mammalian type-C RNA tumour viruses. Nature. 1976 Aug 12; 262(5569):554-9.
      View in: PubMed
    391. Kelloff GJ, Peters RL, Donahoe RM, Stephenson JR, Aaronson SA. Natural occurrence of tumors in mouse strains with different xenotropic and ecotropic endogenous viruses. J Natl Cancer Inst. 1976 Jul; 57(1):85-9.
      View in: PubMed
    392. Stephenson JR, Hino S, Garrett EW, Aaronson SA. Immunological cross reactivity of Mason-Pfizer monkey virus with type C RNA viruses endogenous to primates. Nature. 1976 Jun 17; 261(5561):609-11.
      View in: PubMed
    393. Hino S, Stephenson JR, Aaronson SA. Radiommunoassays for the 70,000-molecular-weight glycoproteins of endogenous mouse type C viruses: viral antigen expression in normal mouse tissues and sera. J Virol. 1976 Jun; 18(3):933-41.
      View in: PubMed
    394. Stephenson JR, Aaronson SA. Search for antigens and antibodies crossreactive with type C viruses of the woolly monkeys and gibbon ape in animal models and in humans. Proc Natl Acad Sci U S A. 1976 May; 73(5):1725-9.
      View in: PubMed
    395. Stephenson JR, Aaronson SA. Induction of an endogenous B-tropic type C RNA virus from SWR/J mouse embryo cells in tissue culture. Virology. 1976 Apr; 70(2):352-9.
      View in: PubMed
    396. Smith EJ, Stephenson JR, Crittenden LB, Aaronson SA. Avian leukosis-sarcoma virus gene expression. Noncoordinate control of group-specific antigens in virus-negative avian cells. Virology. 1976 Apr; 70(2):493-501.
      View in: PubMed
    397. Phillips SM, Stephenson JR, Greenberger JS, Lane PE, Aaronson SA. Release of xenotropic type C RNA virus in response to lipopolysaccharide: acitivity of lipid-A portion upon B lymphocytes. J Immunol. 1976 Apr; 116(4):1123-8.
      View in: PubMed
    398. Okabe H, Gilden RV, Hatanaka M, Stephenson JR, Gallagher RE, Aaronson SA, Gallo RC, Tronick SR. Immunological and biochemical characterisation of type C viruses isolated from cultured human AML cells. Nature. 1976 Mar 18; 260(5548):264-6.
      View in: PubMed
    399. Stephenson JR, Reynolds RK, Aaronson SA. Comparisons of the immunological properties of two structural polypeptides of type C RNA viruses endogenous to old world monkeys. J Virol. 1976 Feb; 17(2):374-84.
      View in: PubMed
    400. Hampar B, Aaronson SA, Derge JG, Chakrabarty M, Showalter SD, Dunn CY. Activation of an endogenous mouse type C virus by ultraviolet-irradiated herpes simplex virus types 1 and 2. Proc Natl Acad Sci U S A. 1976 Feb; 73(2):646-50.
      View in: PubMed
    401. Gonda MA, Aaronson SA, Ellmore N, Zeve VH, Nagashima K. Ultrastructural studies of surface features of human normal and tumor cells in tissue culture by scanning and transmission electron microscopy. J Natl Cancer Inst. 1976 Feb; 56(2):245-63.
      View in: PubMed
    402. Greenberger JS, Bensinger WI, Aaronson SA. Selective techniques for the isolation of morphological revertants of sarcoma virus-transformed cells. Methods Cell Biol. 1976; 14:237-49.
      View in: PubMed
    403. Tronick SR, Stephenson JR, Verma IM, Aaronson SA. Thermolabile reverse transcriptase of a mammalian leukemia virus mutant temperature sensitive in its replication and sarcoma virus helper functions. J Virol. 1975 Dec; 16(6):1476-82.
      View in: PubMed
    404. Aaronson SA, Stephenson JR, Hino S, Tronick SR. Differential expression of helper viral structural polypeptides in cells transformed by clonal isolates of woolly monkey sarcoma virus. J Virol. 1975 Nov; 16(5):1117-23.
      View in: PubMed
    405. Aaronson SA, Stephenson JR, Tronick SR, Hino S. Immunological analysis of structural polypeptides of woolly monkey-gibbon ape type C viruses. Expression of woolly monkey helper viral antigens in cells transformed by woolly monkey sarcoma virus. Bibl Haematol. 1975 Oct; (43):102-9.
      View in: PubMed
    406. Stephension JR, Reynolds RK, Tronick SR, Aaronson SA. Distribution of three classes of endogenous type-C RNA viruses among inbred strains of mice. Virology. 1975 Oct; 67(2):404-14.
      View in: PubMed
    407. Hino S, Stephenson JR, Aaronson SA. Antigenic determinants of the 70,000 molecular weight glycoprotein of woolly monkey type C RNA virus. J Immunol. 1975 Oct; 115(4):922-7.
      View in: PubMed
    408. Greenberger JS, Aaronson SA, Rosenthal DS, Moloney WC. Continuous production of peroxidase, esterase, alkaline phosphatase and lysozyme by clones of promyelocytes. Nature. 1975 Sep 11; 257(5522):143-4.
      View in: PubMed
    409. Dunn CY, Aaronson SA, Stephenson JR. Interactions of chemical inducers and steroid enhancers of endogenous mouse type-C RNA viruses. Virology. 1975 Aug; 66(2):579-88.
      View in: PubMed
    410. Stephenson JR, Smith EJ, Crittenden LB, Aaronson SA. Analysis of antigenic determinants of structural polypeptides of avian type C tumor viruses. J Virol. 1975 Jul; 16(1):27-33.
      View in: PubMed
    411. Greenberger JS, Rosenthal DS, Aaronson SA, Moloney WC. Acute myelogenous leukemia of the Wistar/Furth rat: establishment of a continuous tissue culture line producing lysozyme in vitro and in vivo. Blood. 1975 Jul; 46(1):27-38.
      View in: PubMed
    412. Greenberger JS, Phillips SM, Stephenson JR, Aaronson SA. Induction of mouse type-C RNA virus by lipopolysaccharide. J Immunol. 1975 Jul; 115(1):317-20.
      View in: PubMed
    413. Greenberger JS, Stephenson JR, Aaronson SA. Temperature-sensitive mutants of murine leukemia virus. V. Impaired leukemogenic activity in vivo. Int J Cancer. 1975 Jun 15; 15(6):1009-15.
      View in: PubMed
    414. Stephenson JR, Cabradilla CD, Aaronson SA. Genetic factors influencing endogenous type-C RNA viruses of mouse cells: control of viral polypeptide expression in the C57BL/10 strain. Intervirology. 1975-1976; 6(4-5):258-69.
      View in: PubMed
    415. Aaronson SA, Schlom J. The search for RNA tumor viruses in human cancer. Prog Clin Cancer. 1975; 6:51-63.
      View in: PubMed
    416. Greenberger JS, Stephenson JR, Moloney WC, Aaronson SA. Different hematological diseases induced by type C viruses chemically activated from embryo cells of different mouse strains. Cancer Res. 1975 Jan; 35(1):245-52.
      View in: PubMed
    417. Tronick SR, Stephenson JR, Aaronson SA, Kawakami TG. Antigenic characterization of type C RNA virus isolates of gibbon apes. J Virol. 1975 Jan; 15(1):115-20.
      View in: PubMed
    418. Greenberger JS, Aaronson SA. Cycloheximide induction of xenotropic type C virus from synchronized mouse cells: metabolic requirements for virus activation. J Virol. 1975 Jan; 15(1):64-70.
      View in: PubMed
    419. Stephenson JR, Aaronson SA. Genetics of endogenous mouse C-type viruses. Bibl Haematol. 1975; (40):657-8.
      View in: PubMed
    420. Aaronson SA, Stephenson JR. Differential cellular regulation of three distinct classes of type C RNA viruses endogenous to mouse cells. Cold Spring Harb Symp Quant Biol. 1975; 39 Pt 2:1129-37.
      View in: PubMed
    421. Patni NJ, Billmire E, Aaronson S. Isolation of the Ochromanas danica plasma membrane and identification of several membrane enzymes. Biochim Biophys Acta. 1974 Dec 24; 373(3):347-55.
      View in: PubMed
    422. Stephenson JR, Aaronson SA. Demonstration of a genetic factor influencing spontaneous release of a xenotropic virus of mouse cells. Proc Natl Acad Sci U S A. 1974 Dec; 71(12):4925-9.
      View in: PubMed
    423. Stephenson JR, Tronick SR, Aaronson SA. Isolation from BALB/c mouse cells of a structural polypeptide of a third endogenous type C virus. Cell. 1974 Dec; 3(4):347-53.
      View in: PubMed
    424. Aaronson SA, Anderson GR, Dunn CY, Robbins KC. Induction of type-C RNA virus by cycloheximide: increased expression of virus-specific RNA. Proc Natl Acad Sci U S A. 1974 Oct; 71(10):3941-5.
      View in: PubMed
    425. Lee JC, Hanna MG, Ihle JN, Aaronson SA. Autogenous immunity to endogenous RNA tumor virus: differential reactivities of immunoglobulins M and G to virus envelope antigens. J Virol. 1974 Oct; 14(4):773-81.
      View in: PubMed
    426. Stephenson JR, Tronick SR, Aaronson SA. Temperature-sensitive mutants of murine leukemia virus. IV. Further physiological characterization and evidence for genetic recombination. J Virol. 1974 Oct; 14(4):918-23.
      View in: PubMed
    427. Stephenson JR, Crow JD, Aaronson SA. Differential activation of biologically distinguishable endogenous mouse type C RNA viruses: interaction with host cell regulatory factors. Virology. 1974 Oct; 61(2):411-9.
      View in: PubMed
    428. Aoki T, Stephenson JR, Aaronson SA, Hsu KC. Surface antigens of mammalian sarcoma virus-transformed nonproducer cells. Proc Natl Acad Sci U S A. 1974 Sep; 71(9):3445-9.
      View in: PubMed
    429. Stephenson JR, Aaronson SA, Arnstein P, Huebner RJ, Tronick SR. Demonstration of two immunologically distinct xenotropic type C RNA viruses of mouse cells. Virology. 1974 Sep; 61(1):56-63.
      View in: PubMed
    430. Greenberger JS, Stephenson JR, Aoki T, Aaronson SA. Cell-surface antigens of murine sarcoma-virus-transformed non-producer cells: further evidence for lack of transplantation immunity. Int J Cancer. 1974 Aug 15; 14(2):145-52.
      View in: PubMed
    431. Greenberger JS, Anderson GR, Aaronson SA. Transformation-defective virus mutants in a class of morphologic revertants of sarcoma virus transformed nonproducer cells. Cell. 1974 Aug; 2(4):279-86.
      View in: PubMed
    432. Tronick SR, Stephenson JR, Aaronson SA. Immunological properties of two polypeptides of Mason-Pfizer monkey virus. J Virol. 1974 Jul; 14(1):125-32.
      View in: PubMed
    433. Patni NJ, Aaronson S. The nutrition, resistance to antibiotics and ultrastructure of Prototheca wickerhamii. J Gen Microbiol. 1974 Jul; 83(0):179-82.
      View in: PubMed
    434. Stephenson JR, Anderson GR, Tronick SR, Aaronson SA. Evidence for genetic recombination between endogenous and exogenous mouse RNA type C viruses. Cell. 1974 Jun; 2(2):87-94.
      View in: PubMed
    435. Aaronson SA, Stephenson JR, Greenberger JS. Cellular replication and the persistence of inducible RNA type C viruses. J Virol. 1974 Jun; 13(6):1404-7.
      View in: PubMed
    436. Aaronson SA, Stephenson JR. Widespread natural occurrence of high titers of neutralizing antibodies to a specific class of endogenous mouse type-C virus. Proc Natl Acad Sci U S A. 1974 May; 71(5):1957-61.
      View in: PubMed
    437. Patni NJ, Aaronson S, Holik KJ, Davis RH. Existence of acid and alkaline phosphohydrolase activity in the phytoflagellate Ochromonas danica. Arch Mikrobiol. 1974 Apr 10; 97(1):63-7.
      View in: PubMed
    438. Stephenson JR, Tronick SR, Aaronson SA. Analysis of type specific antigenic determinants of two structural polypeptides of mouse RNA C-Type viruses. Virology. 1974 Mar; 58(1):1-8.
      View in: PubMed
    439. Stephenson JR, Aaronson SA. Temperature-sensitive mutants of murine leukemia virus. 3. Mutants defective in helper functions for sarcoma virus fixation. Virology. 1974 Mar; 58(1):294-7.
      View in: PubMed
    440. Aaronson SA, Dunn CY. High-frequency C-type virus induction by inhibitors of protein synthesis. Science. 1974 Feb 1; 183(4123):422-4.
      View in: PubMed
    441. Tronick SR, Stephenson JR, Aaronson SA. Comparative immunological studies of RNA C-type viruses: radioimmunoassay for a low molecular weight polypeptide of woolly monkey leukemia virus. Virology. 1974 Feb; 57(2):347-56.
      View in: PubMed
    442. Fishman PH, Brady RO, Bradley RM, Aaronson SA, Todaro GJ. Absence of a specific ganglioside galactosyltransferase in mouse cells transformed by murine sarcoma virus. Proc Natl Acad Sci U S A. 1974 Feb; 71(2):298-301.
      View in: PubMed
    443. Greenberger JS, Aaronson SA. Morphologic revertants of murine sarcoma virus transformed nonproducer BALB-3T3: selective techniques for isolation and biologic properties in vitro and in vivo. Virology. 1974 Feb; 57(2):339-46.
      View in: PubMed
    444. Stephenson JR, Tronick SR, Reynolds RK, Aaronson SA. Isolation and characterization of C-type viral gene products of virus-negative mouse cells. J Exp Med. 1974 Feb 1; 139(2):427-38.
      View in: PubMed
    445. Aaronson S, Behrens U. Ultrastructure of an unusual contractile vacuole in several chrysomonad phytoflagellates. J Cell Sci. 1974 Jan; 14(1):1-9.
      View in: PubMed
    446. Stephenson JR, Greenberger JS, Aaronson SA. Oncogenicity of an endogenous C-type virus chemically activated from mouse cells in culture. J Virol. 1974 Jan; 13(1):237-40.
      View in: PubMed
    447. Aaronson SA, Dunn CY. Endogenous C-type viruses of BALB-c cells: frequencies of spontaneous and chemical induction. J Virol. 1974 Jan; 13(1):181-5.
      View in: PubMed
    448. Greenberger JS, Aaronson SA. In vivo inoculation of RNA C-type viruses inducing regression of experimental solid tumors. J Natl Cancer Inst. 1973 Dec; 51(6):1935-8.
      View in: PubMed
    449. Giard DJ, Aaronson SA, Todaro GJ, Arnstein P, Kersey JH, Dosik H, Parks WP. In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors. J Natl Cancer Inst. 1973 Nov; 51(5):1417-23.
      View in: PubMed
    450. Stephenson JR, Aaronson SA. Expression of endogenous RNA C-type virus group-specific antigens in mammalian cells. J Virol. 1973 Sep; 12(3):564-9.
      View in: PubMed
    451. Gelb LD, Milstien JB, Martin MA, Aaronson SA. Characterization of murine leukaemia virus-specific DNA present in normal mouse cells. Nat New Biol. 1973 Jul 18; 244(133):76-9.
      View in: PubMed
    452. Aaronson SA, Stephenson JR. Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proc Natl Acad Sci U S A. 1973 Jul; 70(7):2055-8.
      View in: PubMed
    453. Stephenson JR, Aaronson SA. Characterization of temperature-sensitive mutants of murine leukemia virus. Virology. 1973 Jul; 54(1):53-9.
      View in: PubMed
    454. Tronick SR, Stephenson JR, Aaronson SA. Immunological characterization of a low molecular weight polypeptide of murine leukemia virus. Virology. 1973 Jul; 54(1):199-206.
      View in: PubMed
    455. Stephenson JR, Wilsnack RE, Aaronson SA. Radioimmunoassay for avian C-type virus group-specific antigen: detection in normal and virus-transformed cells. J Virol. 1973 Jun; 11(6):893-9.
      View in: PubMed
    456. Kersey JH, Yunis EJ, Todaro GJ, Aaronson SA. HL-A antigens of human tumor-derived cell lines and viral transformed fibroblasts in culture. Proc Soc Exp Biol Med. 1973 Jun; 143(2):453-6.
      View in: PubMed
    457. Stephenson JR, Aaronson SA. Segregation of loci for C-type virus induction in strains of mice with high and low incidence of leukemia. Science. 1973 May 25; 180(4088):865-6.
      View in: PubMed
    458. Aaronson SA. Biologic characterization of mammalian cells transformed by a primate sarcoma virus. Virology. 1973 Apr; 52(2):562-7.
      View in: PubMed
    459. Aaronson S. Crystalline structures and myelin-like figures in Ochromonas mitochondria. Microbios. 1973 Apr-May; 7(28):231-3.
      View in: PubMed
    460. Aoki T, Stephenson JR, Aaronson SA. Demonstration of a cell-surface antigen associated with murine sarcoma virus by immunoelectron microscopy. Proc Natl Acad Sci U S A. 1973 Mar; 70(3):742-6.
      View in: PubMed
    461. Stephenson JR, Reynolds RK, Aaronson SA. Characterization of morphologic revertants of murine and avian sarcoma virus-transformed cells. J Virol. 1973 Feb; 11(2):218-22.
      View in: PubMed
    462. Todaro GJ, Scolnick EM, Parks WP, Livingston DM, Aaronson SA. Detection of type C viruses in normal and transformed cells. Johns Hopkins Med J Suppl. 1973; 2:231-44.
      View in: PubMed
    463. Todaro GJ, Aaronson SA, Scolnick EM, Ross J, Parks WP. Reverse transcriptases of RNA tumor viruses: immunological relationships. Bibl Haematol. 1973; 39:269-71.
      View in: PubMed
    464. Aaronson S. Particle aggregation and phagotrophy by Ochromonas. Arch Mikrobiol. 1973; 92(1):39-44.
      View in: PubMed
    465. Aaronson SA. Immunologic detection of C-type RNA viral reverse transcriptases. Natl Cancer Inst Monogr. 1972 Dec; 35:83-7.
      View in: PubMed
    466. Stephenson JR, Aaronson SA. A genetic locus for inducibility of C-type in BALB-c cells: the effect of a nonlinked regulatory gene on detection of virus after chemical activation. Proc Natl Acad Sci U S A. 1972 Oct; 69(10):2798-801.
      View in: PubMed
    467. Scolnick EM, Stephenson JR, Aaronson SA. Isolation of temperature-sensitive mutants of murine sarcoma virus. J Virol. 1972 Oct; 10(4):653-7.
      View in: PubMed
    468. Lytle CD, Aaronson SA, Harvey E. Host-cell reactivation in mammalian cells. II. Survival of herpes simplex virus and vaccinia virus in normal human and xeroderma pigmentosum cells. Int J Radiat Biol Relat Stud Phys Chem Med. 1972 Aug; 22(2):159-65.
      View in: PubMed
    469. Stephenson JR, Aaronson SA. Genetic factors influencing C-type RNA virus induction. J Exp Med. 1972 Jul 1; 136(1):175-84.
      View in: PubMed
    470. Stephenson JR, Reynolds RK, Aaronson SA. Isolation of temperature-sensitive mutants of murine leukemia virus. Virology. 1972 Jun; 48(3):749-56.
      View in: PubMed
    471. Stephenson JR, Scolnick EM, Aaronson SA. Genetic stability of the sarcoma viruses in murine and avian sarcoma virus-transformed nonproducer cells. Int J Cancer. 1972 May 15; 9(3):577-83.
      View in: PubMed
    472. Aaronson SA, Bassin RH, Weaver C. Comparison of murine sarcoma viruses in nonproducer and S + L - -transformed cells. J Virol. 1972 Apr; 9(4):701-4.
      View in: PubMed
    473. Kersey JH, Gatti RA, Good RA, Aaronson SA, Todaro GJ. Susceptibility of cells from patients with primary immunodeficiency diseases to transformation by simian virus 40. Proc Natl Acad Sci U S A. 1972 Apr; 69(4):980-2.
      View in: PubMed
    474. Stephenson JR, Aaronson SA. Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells. J Exp Med. 1972 Mar 1; 135(3):503-15.
      View in: PubMed
    475. Scolnick EM, Parks WP, Todaro GJ, Aaronson SA. Immunological characterization of primate C-type virus reverse transcriptases. Nat New Biol. 1972 Jan 12; 235(54):35-40.
      View in: PubMed
    476. Parks WP, Scolnick EM, Ross J, Todaro GJ, Aaronson SA. Immunological relationships of reverse transcriptases from ribonucleic acid tumor viruses. J Virol. 1972 Jan; 9(1):110-5.
      View in: PubMed
    477. Aaronson SA. Chemical induction of focus-forming virus from nonproducer cells transformed by murine sarcoma virus. Proc Natl Acad Sci U S A. 1971 Dec; 68(12):3069-72.
      View in: PubMed
    478. Stephenson JR, Aaronson SA. Murine sarcoma and leukemia viruses: genetic differences determined by RNA-DNA hybridization. Virology. 1971 Nov; 46(2):480-4.
      View in: PubMed
    479. Aaronson SA, Weaver CA. Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells. J Gen Virol. 1971 Nov; 13(2):245-52.
      View in: PubMed
    480. Aaronson SA, Todaro GJ, Scolnick EM. Induction of murine C-type viruses from clonal lines of virus-free BALB-3T3 cells. Science. 1971 Oct 8; 174(4005):157-9.
      View in: PubMed
    481. Gelb LD, Aaronson SA, Martin MA. Heterogeneity of murine leukemia virus in vitro DNA; detection of viral DNA in mammalian cells. Science. 1971 Jun 25; 172(3990):1353-5.
      View in: PubMed
    482. Ross J, Scolnick EM, Todaro GJ, Aaronson SA. Separation of murine cellular and murine leukaemia virus DNA polymerases. Nat New Biol. 1971 Jun 9; 231(23):163-7.
      View in: PubMed
    483. Aaronson S, Behrens U, Orner R, Haines TH. Ultrastructure of intracellular and extracellular vesicles, membranes, and myelin figures produced by Ochromonas danica. J Ultrastruct Res. 1971 Jun; 35(5):418-30.
      View in: PubMed
    484. Aaronson SA, Parks WP, Scolnick EM, Todaro GJ. Antibody to the RNA-dependent DNA polymerase of mammalian C-type RNA tumor viruses. Proc Natl Acad Sci U S A. 1971 May; 68(5):920-4.
      View in: PubMed
    485. Aaronson SA. Common genetic alterations of RNA tumour viruses grown in human cells. Nature. 1971 Apr 16; 230(5294):445-7.
      View in: PubMed
    486. Aaronson SA. Isolation of a rat-tropic helper virus from M-MSV-O stocks. Virology. 1971 Apr; 44(1):29-36.
      View in: PubMed
    487. Todaro GJ, Zeve V, Aaronson SA. Cell culture techniques in the search for cancer viruses of man. In Vitro. 1971 Mar-Apr; 6(5):355-61.
      View in: PubMed
    488. Todaro GJ, Aaronson SA, Rands E. Rapid detection of mycoplasma-infected cell cultures. Exp Cell Res. 1971 Mar; 65(1):256-7.
      View in: PubMed
    489. Worthington M, Aaronson SA. Interferon system in cells from human tumors and from persons predisposed to cancer. Infect Immun. 1971 Mar; 3(3):424-8.
      View in: PubMed
    490. Scolnick EM, Aaronson SA, Todaro GJ, Parks WP. RNA dependent DNA polymerase activity in mammalian cells. Nature. 1971 Jan 29; 229(5283):318-21.
      View in: PubMed
    491. Parks WP, Todaro GJ, Scolnick EM, Aaronson SA. RNA dependent DNA polymerase in primate syncytium-forming (foamy) viruses. Nature. 1971 Jan 22; 229(5282):258-60.
      View in: PubMed
    492. Stone LB, Scolnick E, Takemoto KK, Aaronson SA. Visna virus: a slow virus with an RNA dependent DNA polymerase. Nature. 1971 Jan 22; 229(5282):257-8.
      View in: PubMed
    493. Aaronson S. Inhibition of yeast multiplication by hypocholesteremic compounds and its annulment by lipids. Proc Soc Exp Biol Med. 1971 Jan; 136(1):61-3.
      View in: PubMed
    494. Kelloff G, Aaronson SA, Gilden RV. Inactivation of murine sarcoma and leukemia viruses by ultra-violet irradiation. Virology. 1970 Dec; 42(4):1133-5.
      View in: PubMed
    495. Scolnick E, Rands E, Aaronson SA, Todaro GJ. RNA-dependent DNA polymerase activity in five RNA viruses: divalent cation requirements. Proc Natl Acad Sci U S A. 1970 Dec; 67(4):1789-96.
      View in: PubMed
    496. Aaronson SA, Martin MA. Transformation of human cells with different forms of SV40 DNA. Virology. 1970 Dec; 42(4):848-56.
      View in: PubMed
    497. Gerwin BI, Todaro GJ, Zeve V, Scolnick EM, Aaronson SA. Separation of RNA-dependent DNA polymerase activity from the murine leukaemia virion. Nature. 1970 Oct 31; 228(5270):435-8.
      View in: PubMed
    498. Aaronson SA, Lytle CD. Decreased host cell reactivation of irradiated SV40 virus in xeroderma pigmentosum. Nature. 1970 Oct 24; 228(5269):359-61.
      View in: PubMed
    499. Scolnick EM, Aaronson SA, Todaro GJ. DNA synthesis by RNA-containing tumor viruses. Proc Natl Acad Sci U S A. 1970 Oct; 67(2):1034-41.
      View in: PubMed
    500. Aaronson SA. Susceptibility of human cell strains to transformation by simian virus 40 and simian virus 40 deoxyribonucleic acid. J Virol. 1970 Oct; 6(4):470-5.
      View in: PubMed
    501. Aaronson SA. Effect of ultraviolet irradiation on the survival of simian virus 40 functions in human and mouse cells. J Virol. 1970 Oct; 6(4):393-9.
      View in: PubMed
    502. Aaronson SA, Rowe SP. Nonproducer clones of murine sarcoma virus transformed BALB-3T3 cells. Virology. 1970 Sep; 42(1):9-19.
      View in: PubMed
    503. Aaronson SA, Jainchill JL, Todaro GJ. Murine sarcoma virus transformation of BALB-3T3 cells: lack of dependence on murine leukemia virus. Proc Natl Acad Sci U S A. 1970 Aug; 66(4):1236-43.
      View in: PubMed
    504. Aaronson SA, Todaro GJ, Freeman AE. Human sarcoma cells in culture. Identification by colony-forming ability on monolayers of normal cells. Exp Cell Res. 1970 Jul; 61(1):1-5.
      View in: PubMed
    505. Todaro GJ, Zeve V, Aaronson SA. Viruses in cell culture derived from human tumour patients. Nature. 1970 Jun 13; 226(5250):1047-9.
      View in: PubMed
    506. Aaronson SA, Todaro GJ. Infectious SV40 and SV40 DNA: rapid fluorescent focus assay. Proc Soc Exp Biol Med. 1970 May; 134(1):103-6.
      View in: PubMed
    507. Aaronson SA, Todaro GJ. Transformation and virus growth by murine sarcoma viruses in human cells. Nature. 1970 Jan 31; 225(5231):458-9.
      View in: PubMed
    508. Pollock EJ, Aaronson SA, Todaro GJ. X-irradiation of Balb-3T3. Sarcoma-forming ability and virus induction. Int J Radiat Biol Relat Stud Phys Chem Med. 1970; 17(1):97-100.
      View in: PubMed
    509. Grusky GE, Aaronson S. Cytochemical changes in aging Ochromonas; evidence for an alkaline phosphatase. J Protozool. 1969 Nov; 16(4):686-9.
      View in: PubMed
    510. Jainchill JL, Aaronson SA, Todaro GJ. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells. J Virol. 1969 Nov; 4(5):549-53.
      View in: PubMed
    511. Aaronson S, Todaro S. Human diploid cell transformation by DNA extracted from the tumor virus SV40. Science. 1969 Oct 17; 166(3903):390-1.
      View in: PubMed
    512. Aaronson SA, Hartley JW, Todaro GJ. Mouse leukemia virus: "spontaneous" release by mouse embryo cells after long-term in vitro cultivation. Proc Natl Acad Sci U S A. 1969 Sep; 64(1):87-94.
      View in: PubMed
    513. Todaro GJ, Aaronson SA. Properties of clonal lines of murine sarcoma virus transformed Balb-3T3 cells. Virology. 1969 May; 38(1):174-9.
      View in: PubMed
    514. Aaronson S, Roze U, Keane M, Zahalsky AC. [Inhibition of Ochromonas respiration by hypocholesteremic compounds and its annulment by unsaturated fatty acids]. J Protozool. 1969 Feb; 16(1):184-6.
      View in: PubMed
    515. Todaro GJ, Aaronson SA. Human cell strains susceptible to focus formation by human adenovirus type 12. Proc Natl Acad Sci U S A. 1968 Dec; 61(4):1272-8.
      View in: PubMed
    516. Aaronson SA, Todaro GJ. Basis for the acquisition of malignant potential by mouse cells cultivated in vitro. Science. 1968 Nov 29; 162(3857):1024-6.
      View in: PubMed
    517. Aaronson SA, Todaro GJ. SV40 T antigen induction and transformation in human fibroblast cell strains. Virology. 1968 Oct; 36(2):254-61.
      View in: PubMed
    518. Aaronson SA, Todaro GJ. Development of 3T3-like lines from Balb-c mouse embryo cultures: transformation susceptibility to SV40. J Cell Physiol. 1968 Oct; 72(2):141-8.
      View in: PubMed
    519. Schuster FL, Hershenov B, Aaronson S. Ultrastructureal observations on aging of stationary cultures and feeding in Ochromonas. J Protozool. 1968 May; 15(2):335-46.
      View in: PubMed
    520. Aaronson S, Fulco L. Effect of hypocholesteremic compounds on bacterial multiplication. J Gen Microbiol. 1968 Feb; 50(2):271-6.
      View in: PubMed
    521. Aaronson SA. A cephalometric investigation of the surgical correction of mandibular prognathism. Angle Orthod. 1967 Oct; 37(4):251-60.
      View in: PubMed
    522. Aaronson S, Ellenbogen BB, Yellen LK, Hutner SH. In vivo differentiation of Euglena cytoplasmic and chloroplast protein synthesis with chloramphenicol and DL-ethionine. Biochem Biophys Res Commun. 1967 Jun 9; 27(5):535-8.
      View in: PubMed
    523. Aaronson SA, Korner A, Munro AJ. Inhibition by soluble ribonucleic acid of stimulatory effect of liver template ribonucleic acid. Biochem J. 1966 Nov; 101(2):448-53.
      View in: PubMed
    524. Aaronson S. Study of the cellular action of drugs with protozoa--3. Comparison of the effect of SKF 525-A and related compounds on the multiplication of Ochromonas danica. Biochem Pharmacol. 1966 Aug; 15(8):1241-4.
      View in: PubMed
    525. Aaronson S, Hutner SH. Biochemical markers and microbial phylogeny. Q Rev Biol. 1966 Mar; 41(1):13-46.
      View in: PubMed
    526. Aaronson SA, Natori Y, Tarver H. Effect of estrogen on uterine ATP levels. Proc Soc Exp Biol Med. 1965 Oct; 120(1):9-10.
      View in: PubMed
    527. Aaronson S. Inhibition of microbial multiplication by hypocholesteraemic compounds. J Gen Microbiol. 1965 Jun; 39(3):367-71.
      View in: PubMed
    528. Aaronson S, Bensky B. Study of the cellular action of drugs with protozoa. II. Comparative study of the inhibitions induced by hypocholesteremic agents on Ochromonas danica multiplication; annulment by oleic acid. J Protozool. 1965 May; 12(2):236-40.
      View in: PubMed
    529. AARONSON S. A ROLE FOR A STEROL AND A STEROL PRECURSOR IN THE BACTERIUM RHODOPSEUDOMONAS PALUSTRIS. J Gen Microbiol. 1964 Nov; 37:225-9.
      View in: PubMed
    530. AARONSON S. INHIBITION OF RESPIRATION IN A FLAGELLATE PROTOZOON BY HYPOCHOLESTEROLEMIC DRUGS. Nature. 1964 Jun 27; 202:1355.
      View in: PubMed
    531. FRANK O, BAKER H, ZIFFER H, AARONSON S, HUTNER SH, LEEVY CM. Metabolic deficiencies in protozoa induced by thalidomide. Science. 1963 Jan 11; 139(3550):110-1.
      View in: PubMed
    532. AARONSON S, BENSKY B. Study of the cellular action of drugs with protozoa. I. Effect of 1-aminocyclopentane-1-carboxylic acid and 1-amino-3-methylcyclohexane-1-carboxylic acid on the phytoflagellate Ochromonas danica. Biochem Pharmacol. 1962 Nov; 11:983-6.
      View in: PubMed
    533. HOLZ GG, ERWIN J, ROSENBAUM N, AARONSON S. Triparanol inhibition of Tetrahymena, and its prevention by lipids. Arch Biochem Biophys. 1962 Aug; 98:312-22.
      View in: PubMed
    534. BAKER H, FRANK O, HUTNER SH, AARONSON S, ZIFFER H, SOBOTKA H. Lesions in folic acid metabolism induced by primidone. Experientia. 1962 May 15; 18:224-6.
      View in: PubMed
    535. AARONSON S, BENSKY B, SHIFRINE M, BAKER H. Effect of hypocholesteremic agents on protozoa. Proc Soc Exp Biol Med. 1962 Jan; 109:130-2.
      View in: PubMed
    536. AARONSON S, BENSKY B. O-Methylthreonine, a new bleaching agent for Euglena gracilis. J Gen Microbiol. 1962 Jan; 27:75-88.
      View in: PubMed
    537. BAKER H, FRANK O, MATOVITCH VB, PASHER I, AARONSON S, HUTNER SH, SOBOTKA H. A new assay method for biotin in blood, serum, urine, and tissues. Anal Biochem. 1962 Jan; 3:31-9.
      View in: PubMed
    538. AARONSON S, LESSIE T. Nonulosaminic acid (sialic acid) in protists. Nature. 1960 May 28; 186:719.
      View in: PubMed
    539. BAKER H, FRANK O, PASHER I, SOBOTKA H, NATHAN HA, HUNTER SH, AARONSON S. Elaboration of vitamin B12 by Escherichia coli. Experientia. 1960 May 15; 16:187.
      View in: PubMed
    540. HUTNER SH, NATHAN HA, BAKER H, SOBOTKA H, AARONSON S. Some microbiologic prospects for discerning vitamin interrelationships. Am J Clin Nutr. 1959 Jul-Aug; 7:407-10.
      View in: PubMed
    541. AARONSON S. Mode of action of azaserine on Gaffkya homari. J Bacteriol. 1959 May; 77(5):548-51.
      View in: PubMed
    542. BAKER H, PASHER I, FRANK O, HUTNER SH, AARONSON S, SOBOTKA H. Assay of thiamine in biologic fluids. Clin Chem. 1959 Feb; 5(1):13-7.
      View in: PubMed
    543. HUTNER SH, NATHAN HA, AARONSON S, BAKER H, SCHER S. General considerations in the use of microorganisms in screening antitumor agents. Ann N Y Acad Sci. 1958 Dec 5; 76(3):457-68.
      View in: PubMed
    544. AARONSON S, RODRIGUEZ E. Relationship between purines and folic acid-vitamins in the micrococcus, Gaffkya homari. J Bacteriol. 1958 Jun; 75(6):660-5.
      View in: PubMed
    545. AARONSON S, RODRIGUEZ E. Utilization of purines and their derivatives by Gaffkya homari. J Bacteriol. 1957 Dec; 74(6):807-10.
      View in: PubMed
    546. BAKER H, PASHER I, SOBOTKA H, HUTNER SH, AARONSON S, ZIFFER H. Vitamin B12 distribution between plasma and cells. Nature. 1957 Nov 16; 180(4594):1043-4.
      View in: PubMed
    547. AARONSON S. A biochemical-taxonomic study of a marine micrococcus, Gaffkya homari, and a terrestrial counterpart. J Gen Microbiol. 1956 Dec; 15(3):478-84.
      View in: PubMed
    548. AARONSON S. The purine requirement of Staphylococcus flavocyaneus. J Gen Microbiol. 1955 Feb; 12(1):147-55.
      View in: PubMed
    549. AARONSON S. Biotin assay with a coccus, Micrococcus sodonensis, nov. sp. J Bacteriol. 1955 Jan; 69(1):67-9.
      View in: PubMed
    550. AARONSON S, NATHAN HA. Utilization of imidazole counterparts of purines in microbial systems. Biochim Biophys Acta. 1954 Oct; 15(2):306-7.
      View in: PubMed
    551. AARONSON S. Notes on the incidence of three nematode parasites in the Manila area. Biol Rev City Coll. 1946 Mar; 8:30.
      View in: PubMed
    Aaronson's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts
    _
    Co-Authors
    _
    Similar People
    _
    Same Department
     
    Mount Sinai Profiles is managed by Conduits - The Institutes for Translational Sciences at Icahn School of Medicine, supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences of the National Institutes of Health through Grant Number UL1TR000067